Depression or dysthymia

F5_DEPRESSION_DYSTHYMIA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions not (F5_SCHIZO or F5_SCHIZOAFF or F5_BIPO	530607
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F32, F33, F34.1 Hospital discharge: ICD-10 — F32, F33, F34.1 Hospital discharge: ICD-9 — 2961\|2968\|3004 Cause of death: ICD-10 — F32, F33 Cause of death: ICD-9 — 2961\|2968\|3004 3 out of 7 registries used, show all original rules.	90035
4. Check minimum number of events None	90035
5. Include endpoints None	90035
6. Filter based on genotype QC (FinnGen only)	81050

Control definitions (FinnGen only)

Control exclude: F5_PSYCH_INCLAVO, ANTIDEPRESSANTS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF9

NAME	F5_DEPRESSION_DYSTHYMIA
CONTROL_EXCLUDE	F5_PSYCH_INCLAVO\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!(F5_SCHIZO\|F5_SCHIZOAFF\|F5_BIPO)
OUTPAT_ICD	F3[2-3]\|F341
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F3[2-3]\|F341
HD_ICD_9	2961\|2968\|3004
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F3[2-3]
COD_ICD_9	2961\|2968\|3004
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Depression or dysthymia based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	81050	57196	23854
Unadjusted period prevalence (%)	17.55	20.31	10.94
Median age at first event (years)	45.07	43.23	49.48

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
42810: Matched controls
233693

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

-1, ,

NOMESCO Finland

1.6

323.3

12208

47216

Z2221

NOMESCO Finland

Medical doctor

1.6

322.7

9545

34772

P81

ICPC

Hyperkinetic disorder

32.1

321.8

338

J01CA04

ATC

amoxicillin; systemic

1.6

321.6

32948

158059

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

20.7

319.8

376

100

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

319.2

4692

13857

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

318.5

2010

4081

SPAT1312

SPAT

General health counselling

1.6

318.1

11567

44307

T74.1

ICD-10 Finland

Physical abuse

6.2

318.1

718

639

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.0

317.2

1730

3227

ZY000

NOMESCO Finland

Hospital inpatient

20.2

316.7

375

102

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.1

316.5

1085

1456

J45

ICD-10 Finland

Asthma

2.1

316.3

3795

10395

A05

ICPC

Feeling ill

2.6

312.1

2300

5070

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

311.8

1462

2476

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

310.3

3610

9766

SPAT1265

SPAT

Breathalyser

20.7

309.4

364

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.2

309.2

620

476

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.5

309.1

2305

5111

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

17591

62939

IHZ02, ,

SPAT

46.8

307.7

650

N06DX01

ATC

memantine; oral

83.3

307.7

1701

116

P06

ICPC

Sleep disturbance

5.5

307.7

6731

7730

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

35.1

307.7

1478

238

M79.6

ICD-10 Finland

Pain in limb

2.0

307.7

18074

62112

SPAT1284

SPAT

Extensive health certificate

4.6

307.7

1068

1296

J02AC01

ATC

fluconazole; systemic

1.7

307.7

14138

51839

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1668

K59.0

ICD-10 Finland

Constipation

2.9

307.7

2022

3905

F06.7

ICD-10 Finland

Mild cognitive disorder

+∞

307.7

919

N05CF02

ATC

zolpidem; oral

5.6

307.7

8709

10263

N05CD07

ATC

temazepam; oral

6.8

307.7

5501

4946

T36

ICD-10 Finland

Poisoning by systemic antibiotics

38.1

307.7

2464

374

L01

ICPC

Neck symptom/complaint

2.3

307.7

6557

17342

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

27.4

307.7

595

120

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.7

307.7

3125

6631

F41.8

ICD-10 Finland

Other specified anxiety disorders

+∞

307.7

1788

R06AE07

ATC

cetirizine; oral

1.7

307.7

16891

65817

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

307.7

4651

12641

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

+∞

307.7

819

Z72.1

ICD-10 Finland

Alcohol use

16.5

307.7

605

203

N02BE01

ATC

paracetamol; systemic, rectal

2.4

307.7

37162

171019

A04

ICPC

Weakness/tiredness general

3.3

307.7

7205

13591

F39

ICD-10 Finland

Unspecified mood [affective] disorder

+∞

307.7

753

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

+∞

307.7

753

F41.00

ICD-10 Finland

Moderate panic disorder

+∞

307.7

802

N06AB06

ATC

sertraline; oral

69.0

307.7

8807

874

SPAT1260

SPAT

Consultation of another employee

1.9

307.7

6197

19437

P70

ICPC

Dementia

14.9

307.7

430

159

F32.1

ICD-10 Finland

Moderate depressive episode

+∞

307.7

6945

IHZ05, ,

SPAT

16.6

307.7

2657

927

WZA10, ,

SPAT

28.0

307.7

547

108

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

18528

70376

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

7.7

307.7

693

497

F03

ICD-10 Finland

Unspecified dementia

+∞

307.7

1003

N05BA12

ATC

alprazolam; oral

11.0

307.7

5563

3124

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.5

307.7

5303

12518

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

307.7

437

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

+∞

307.7

2964

N05AF01

ATC

flupentixol; systemic

29.6

307.7

652

122

F10.25

ICD-10 Finland

Alcohol dependence continuous use

+∞

307.7

918

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

307.7

4559

11366

F41

ICD-10 Finland

Other anxiety disorders

+∞

307.7

810

F45.8

ICD-10 Finland

Other somatoform disorders

+∞

307.7

2360

N02AX02

ATC

tramadol; systemic, rectal

2.1

307.7

18090

59463

C07AB07

ATC

bisoprolol; oral

1.7

307.7

17588

68763

N02BF01

ATC

gabapentin; oral

2.8

307.7

4182

8732

M79.1

ICD-10 Finland

Myalgia

2.2

307.7

5619

15024

J01CA08

ATC

pivmecillinam; oral

1.6

307.7

13375

52402

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.9

307.7

1772

2562

R06AX27

ATC

desloratadine; oral

1.6

307.7

10612

39644

N06AB05

ATC

paroxetine; oral

38.4

307.7

3631

563

M03BX02

ATC

tizanidine; oral

2.0

307.7

25544

99348

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.1

307.7

5937

8876

IAA01, ,

SPAT

28.5

307.7

363

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

307.7

4538

12897

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

307.7

2181

4571

G30.1

ICD-10 Finland

Alzheimer disease with late onset

21.3

307.7

1345

356

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

307.7

14654

55765

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

18671

69672

N03AX12

ATC

[U] gabapentin; oral

3.4

307.7

7175

13101

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

+∞

307.7

2703

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

11350

40553

N03AX16

ATC

[U] pregabalin

3.4

307.7

10678

21020

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

307.7

2625

5798

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.8

307.7

22582

88029

N06AA12

ATC

doxepin; systemic

22.1

307.7

2834

747

F34.1

ICD-10 Finland

Dysthymia

+∞

307.7

3855

N06AA10

ATC

nortriptyline; systemic

10.8

307.7

894

459

IGY02, ,

SPAT

67.2

307.7

643

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

+∞

307.7

2957

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

307.7

4089

L02

ICPC

Back symptom/complaint

2.4

307.7

4021

9872

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

307.7

7428

21187

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

171.8

307.7

2210

M01AH05

ATC

etoricoxib; oral

1.6

307.7

24255

104947

M79.0

ICD-10 Finland

Rheumatism, unspecified

8.2

307.7

1547

1070

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

307.7

2003

3719

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

+∞

307.7

587

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

481.3

307.7

523

Z02.7

ICD-10 Finland

Issue of medical certificate

2.7

307.7

2925

6075

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

11438

31029

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.2

307.7

2116

3771

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

88.4

307.7

1636

105

P74

ICPC

Anxiety disorder/anxiety state

46.2

307.7

2794

353

N05AH04

ATC

quetiapine; oral

42.6

307.7

12335

2197

G44.2

ICD-10 Finland

Tension-type headache

2.9

307.7

5755

11866

N06AA22, ,

ATC

57.6

307.7

314

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

+∞

307.7

952

F43.8

ICD-10 Finland

Other reactions to severe stress

+∞

307.7

1165

N06BA04

ATC

methylphenidate; oral

83.1

307.7

1795

123

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.7

307.7

1154

1382

N01

ICPC

Headache

2.7

307.7

4648

10266

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

+∞

307.7

802

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

307.7

4440

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

307.7

12193

38492

N07BA03

ATC

varenicline; oral

3.3

307.7

1779

3074

P29

ICPC

Psychological sympt/compl other

15.9

307.7

4277

1616

ZY010

NOMESCO Finland

Hospital outpatient

6.8

307.7

2367

1982

SPAT1234

SPAT

Support of social functional capacity

5.1

307.7

1764

1970

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

16115

64205

N05CF01

ATC

zopiclone; oral

5.6

307.7

16650

23921

N06AX16

ATC

venlafaxine; oral

69.3

307.7

12388

1365

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.7

307.7

4361

4566

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

12560

48195

P02

ICPC

Acute stress reaction

6.9

307.7

2306

1903

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.3

307.7

4555

11641

SPAT1053

SPAT

Memory test

2.5

307.7

4252

9838

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

+∞

307.7

718

IBA01, ,

SPAT

18.7

307.7

1082

324

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

307.7

1208

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

307.7

7521

20463

F51

ICD-10 Finland

Nonorganic sleep disorders

+∞

307.7

1891

P58

ICPC

Psychological, Therapeutic counselling/listening

13.2

307.7

973

410

N06DA04

ATC

galantamine; oral

98.7

307.7

465

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

+∞

307.7

649

Z71.8

ICD-10 Finland

Other specified counselling

1.9

307.7

13687

46738

J01DB01

ATC

cefalexin; oral

1.8

307.7

33728

156654

N03AF01

ATC

carbamazepine; oral, rectal

3.2

307.7

1619

2814

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

307.7

504

N06AX11

ATC

mirtazapine; oral

24.8

307.7

24416

11870

M54.4

ICD-10 Finland

Lumbago with sciatica

2.4

307.7

7633

19689

L03

ICPC

Low back symptom/complaint

2.2

307.7

12194

36221

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

970

P76

ICPC

Depressive disorder

154.0

307.7

6391

266

SFA20

NOMESCO Finland

Two-surface restoration

1.7

307.7

23561

98438

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

307.7

6727

21751

G04BD12

ATC

mirabegron; oral

2.1

307.7

4048

10849

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

11422

34417

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

307.7

14895

59136

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

+∞

307.7

1352

R03AC02

ATC

salbutamol; inhalant

1.9

307.7

22556

84959

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

307.7

879

N07BB01

ATC

disulfiram; oral

24.7

307.7

2401

560

D11

ICPC

Diarrhoea

2.5

307.7

4799

11367

N05AF03

ATC

chlorprothixene; systemic

140.3

307.7

708

OAB93, ,

SPAT

5.0

307.7

3096

3600

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7305

22295

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

307.7

4306

12131

F43.29

ICD-10 Finland

Adaptation disorder UNS

+∞

307.7

1067

N03AG01

ATC

valproic acid; systemic, rectal

6.5

307.7

1691

1463

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.3

307.7

1132

1011

N06AX12

ATC

bupropion; oral

107.5

307.7

6381

380

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

+∞

307.7

854

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.2

307.7

5704

15286

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

307.7

11412

38937

F32.8

ICD-10 Finland

Other depressive episodes

+∞

307.7

1379

M01AC06

ATC

meloxicam; systemic, rectal

1.6

307.7

12630

49023

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.3

307.7

1393

1464

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

307.7

2353

5019

R07.3

ICD-10 Finland

Other chest pain

2.2

307.7

3869

9972

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

203.6

307.7

1055

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

307.7

3700

8666

P25

ICPC

Phase of life problem adult

8.9

307.7

2257

1458

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

+∞

307.7

1909

N05AX08

ATC

risperidone; systemic

27.3

307.7

2676

570

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

307.7

9132

27824

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

+∞

307.7

10286

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

307.7

5003

14668

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

307.7

408

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

14301

55985

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

8901

28062

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

15775

48209

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

7213

23628

SPAT1238

SPAT

Brief therapy

19.5

307.7

970

277

Z08

ICPC

Social welfare problem

11.2

307.7

558

275

J01DA01

ATC

[U] cefalexin

1.6

307.7

23460

102442

A06AD11

ATC

lactulose; oral

2.6

307.7

5290

11897

SPAT1307

SPAT

Psychosocial counselling and guidance

8.8

307.7

3143

2092

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

307.7

11228

32971

A06AC01

ATC

ispaghula (psylla seeds); oral

2.3

307.7

10573

28659

C07AA05

ATC

propranolol; systemic

3.8

307.7

9197

15623

N02AA05

ATC

oxycodone; systemic

1.9

307.7

6211

19065

F10.09

ICD-10 Finland

Alcohol intoxication UNS

+∞

307.7

956

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

+∞

307.7

483

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

8.5

307.7

601

389

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

+∞

307.7

2249

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

15094

55589

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

5524

16354

V03AA01, ,

ATC

18.1

307.7

726

222

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

+∞

307.7

1996

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.9

307.7

2412

4737

G43.9

ICD-10 Finland

Migraine, unspecified

3.2

307.7

2204

3953

F43.0

ICD-10 Finland

Acute stress reaction

+∞

307.7

2378

H02AB06

ATC

prednisolone; systemic

1.6

307.7

18257

73307

A28

ICPC

Limited function/disability NOS

2.4

307.7

5978

14849

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.4

307.7

4900

11794

F60.9

ICD-10 Finland

Personality disorder, unspecified

+∞

307.7

511

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

307.7

2052

4046

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

307.7

4582

12591

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2898.8

307.7

530

R02

ICPC

Shortness of breath/dyspnoea

2.2

307.7

5266

13772

G47.3

ICD-10 Finland

Sleep apnoea

2.5

307.7

10544

27181

N06DA03

ATC

rivastigmine; oral, transdermal

63.0

307.7

992

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

307.7

3782

8535

K30

ICD-10 Finland

Functional dyspepsia

2.2

307.7

4269

11322

N06AX21

ATC

duloxetine; oral

25.4

307.7

8920

2395

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

307.7

3359

8298

SPAT1301

SPAT

No procedures

1.8

307.7

11450

39661

M54.2

ICD-10 Finland

Cervicalgia

2.4

307.7

2974

7108

F32

ICD-10 Finland

Depressive episode

+∞

307.7

6646

N05AH03

ATC

olanzapine; systemic

29.5

307.7

1984

384

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

307.7

10769

33321

N05AN01

ATC

lithium; oral

55.1

307.7

400

N05AA02

ATC

levomepromazine; systemic

27.0

307.7

1458

305

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

307.7

592

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

+∞

307.7

541

Z2445

NOMESCO Finland

Psychologist

9.1

307.7

1818

1138

R21

ICPC

Throat symptom/complaint

1.8

307.7

8174

27055

R05

ICPC

Cough

1.8

307.7

9492

32515

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

307.7

9549

33396

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

307.7

17002

61439

N06AB10

ATC

escitalopram; oral

68.3

307.7

17846

2419

J01AA02

ATC

doxycycline; systemic

1.6

307.7

30324

139443

N02BF02

ATC

pregabalin; oral

4.0

307.7

3020

4392

Z73.0

ICD-10 Finland

Burn-out

21.2

307.7

2110

571

P15

ICPC

Chronic alcohol abuse

35.1

307.7

1723

279

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

9258

25433

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

70.2

307.7

1859

151

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

27501

118544

N03AX11

ATC

topiramate; oral

6.2

307.7

807

723

Z29

ICPC

Social problem NOS

6.1

307.7

804

736

D01

ICPC

Abdominal pain/cramps general

2.3

307.7

4871

12527

F33.8

ICD-10 Finland

Other recurrent depressive disorders

+∞

307.7

573

M79.7

ICD-10 Finland

Fibromyalgia

10.7

307.7

1707

906

F05.9

ICD-10 Finland

Delirium, unspecified

+∞

307.7

633

N03AE01

ATC

clonazepam; systemic

7.9

307.7

2604

1895

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

307.7

15794

62660

R51.80

ICD-10 Finland

Headache

2.9

307.7

6865

14340

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

3.1

307.7

3764

7057

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.8

307.7

3260

6656

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

17571

63301

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

+∞

307.7

4912

N05AL01

ATC

sulpiride; systemic

38.3

307.7

588

N06AB08

ATC

fluvoxamine; oral

47.1

307.7

1500

180

XA800

NOMESCO Finland

Neuropsychological investigation

4.1

307.7

1714

2345

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

565.6

307.7

1403

K02.1

ICD-10 Finland

Caries of dentine

1.8

307.7

24472

99491

N06BA12

ATC

lisdexamfetamine; oral

397.3

307.7

504

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

307.7

30287

127187

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

4138

10030

P20

ICPC

Memory disturbance

4.3

307.7

4872

6730

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.2

307.7

1710

3002

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

11950

40731

F43.2

ICD-10 Finland

Adjustment disorders

+∞

307.7

696

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

307.7

8582

28870

N06DA02

ATC

donepezil; oral

43.1

307.7

1264

165

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

198.9

307.7

962

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

14.5

307.7

462

176

F10.20

ICD-10 Finland

Alcohol dependence currently independent

+∞

307.7

1128

F10.24

ICD-10 Finland

Alcohol depence active use

+∞

307.7

810

N06AX22

ATC

agomelatine; oral

271.6

307.7

1765

M54

ICD-10 Finland

Dorsalgia

2.2

307.7

4831

12963

M48.0

ICD-10 Finland

Spinal stenosis

2.1

307.7

4251

11776

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.2

307.7

4782

12493

SPAT1243

SPAT

Psychiatric/psychological examination

31.2

307.7

1375

248

N06AX18

ATC

reboxetine; oral

93.5

307.7

608

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

307.7

3088

7283

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

+∞

307.7

7336

M01AE02

ATC

naproxen; oral, rectal

1.7

307.7

22138

91124

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

+∞

307.7

7419

N03AX09

ATC

lamotrigine; oral

16.9

307.7

1753

588

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

208.3

307.7

860

F40.1

ICD-10 Finland

Social phobias

+∞

307.7

1509

N06AA09

ATC

amitriptyline; systemic

9.1

307.7

4833

3220

A01

ICPC

Pain general/multiple sites

3.0

307.7

4155

7959

A02BC02

ATC

pantoprazole; systemic

2.2

307.7

28433

110681

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1307.6

307.7

723

P99

ICPC

Psychological disorders other

34.3

307.7

1128

184

H03AA01

ATC

levothyroxine sodium; systemic

1.9

307.7

8203

26159

SPAT1254

SPAT

Administration of medicine

2.3

307.7

5363

13434

L08

ICPC

Shoulder symptom/complaint

1.7

307.7

8602

29717

IBA03

NOMESCO Finland

Psychotherapy evaluation

673.4

307.7

488

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.8

307.7

1978

3927

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

+∞

307.7

1206

Z01.2

ICD-10 Finland

Dental examination

1.6

307.7

18527

75005

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

+∞

307.7

624

R51

ICD-10 Finland

Headache

2.8

307.7

2092

4191

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

+∞

307.7

7142

N06CA01

ATC

amitriptyline and psycholeptics; systemic

6.4

307.7

5056

4787

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

23.2

307.7

554

132

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

307.7

5408

16224

N17

ICPC

Vertigo/dizziness

2.1

307.7

4600

12450

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.0

307.7

2740

5264

R53

ICD-10 Finland

Malaise and fatigue

3.7

307.7

12338

23063

F33

ICD-10 Finland

Recurrent depressive disorder

+∞

307.7

1976

F52.2

ICD-10 Finland

Failure of genital response

+∞

307.7

532

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

10056

J01EA01

ATC

trimethoprim; systemic

1.7

307.7

8589

29874

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.5

307.7

4148

9514

F60.5

ICD-10 Finland

Anankastic personality disorder

+∞

307.7

708

F32.9

ICD-10 Finland

Depressive episode, unspecified

+∞

307.7

18065

A02BC05

ATC

esomeprazole; systemic

2.0

307.7

16182

55042

ZYC02, ,

SPAT

4.7

307.7

1094

1289

OAA65, ,

SPAT

2.6

307.7

7709

18052

M25.5

ICD-10 Finland

Pain in joint

1.9

307.7

13097

44486

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

307.7

424

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

526

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

9502

31535

EBA00

NOMESCO Finland

Extraction of tooth

1.7

307.7

14548

53626

F43.01

ICD-10 Finland

Acute stress reaction moderate

+∞

307.7

660

UJF32

NOMESCO Finland

Coloscopy

1.7

307.7

9569

33287

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

16.6

307.7

6258

2379

N05AB01

ATC

dixyrazine; systemic

25.4

307.7

515

112

N05BA04

ATC

oxazepam; oral

12.0

307.7

16382

11464

N04BC05

ATC

pramipexole; oral

3.2

307.7

2830

5037

S06.0

ICD-10 Finland

Concussion

2.7

307.7

4350

9254

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

307.7

5567

N06AX05

ATC

trazodone; oral

85.2

307.7

1507

100

E66.8

ICD-10 Finland

Other obesity

3.2

307.7

2215

3890

R11

ICD-10 Finland

Nausea and vomiting

2.8

307.7

3407

6983

S18

ICPC

Laceration/cut

1.6

307.7

17887

73416

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

+∞

307.7

1036

G30.8

ICD-10 Finland

Other Alzheimer disease

27.9

307.7

451

N30.0

ICD-10 Finland

Acute cystitis

2.0

307.7

6067

17922

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

307.7

10014

36431

F32.0

ICD-10 Finland

Mild depressive episode

+∞

307.7

3047

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

+∞

307.7

1185

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.3

307.7

3825

9557

F43.1

ICD-10 Finland

Post-traumatic stress disorder

+∞

307.7

1385

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

+∞

307.7

479

M54.5

ICD-10 Finland

Low back pain

2.4

307.7

16087

47338

P16

ICPC

Acute alcohol abuse

21.6

307.7

783

201

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

141.4

307.7

888

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

307.7

20498

80504

F41.3

ICD-10 Finland

Other mixed anxiety disorders

+∞

307.7

826

P03

ICPC

Feeling depressed

38.2

307.7

9234

1670

SPAT1283

SPAT

Restricted health certificate

2.1

307.7

6593

18677

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

307.7

725

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.1

307.7

1558

2126

IGY99, ,

SPAT

14.6

307.7

883

336

L28

ICPC

Limited function/disability (L)

2.5

307.7

7325

17686

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.9

307.7

3722

7502

R74

ICPC

Upper respiratory infection acute

1.9

307.7

13362

45696

A02BC01

ATC

omeprazole; systemic

2.0

307.7

10307

32625

R01AD09

ATC

mometasone; nasal

1.6

307.7

17365

69185

R41.3

ICD-10 Finland

Other amnesia

4.7

307.7

980

1164

P27

ICPC

Fear of mental disorder

23.4

307.7

500

118

N06AX26

ATC

vortioxetine; oral

323.2

307.7

7520

154

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

307.7

11703

35172

F41.09

ICD-10 Finland

UNS Panic Syndrome

+∞

307.7

1498

E0000UV, ,

ATC

1.6

307.7

15606

62843

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

20239

85884

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.1

307.7

3371

6319

OAB38, ,

SPAT

7.9

307.7

833

584

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

8.1

307.7

1380

955

Z05

ICPC

Work problem

6.6

307.7

1424

1211

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

307.7

13324

49593

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

7204

19746

P01

ICPC

Feeling anxious/nervous/tense

16.9

307.7

8701

3471

SPAT1240

SPAT

Therapeutic discussion

12.8

307.7

6796

3396

N05BE01

ATC

buspirone; oral

55.6

307.7

1730

177

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

307.7

29800

127313

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.1

307.7

1795

2475

N06AA06

ATC

trimipramine; systemic

36.2

307.7

1232

191

IHZ04, ,

SPAT

41.0

307.7

854

116

A02BA02

ATC

ranitidine; systemic

2.1

307.7

6740

19491

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

307.7

890

IGY99

NOMESCO Finland

Other psychiatric treatment contact

75.4

307.7

919

SPAT1263

SPAT

Sampling

1.7

307.7

15980

60439

SPAT1216

SPAT

Assessment of functional ability

2.4

307.7

5333

13063

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.6

307.7

2412

3863

KMAK, ,

NOMESCO Finland

1.6

307.7

19343

79580

F99

ICD-10 Finland

Mental disorder, not otherwise specified

+∞

307.7

947

N06AB03

ATC

fluoxetine; oral

31.6

307.7

8461

1807

Z3231

NOMESCO Finland

Registered nurse

1.8

307.7

10225

33975

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

10881

32441

N06AG02

ATC

moclobemide; oral

43.4

307.7

2887

389

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

+∞

307.7

575

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

6238

16663

N06AB04

ATC

citalopram; systemic

37.2

307.7

15623

3554

N05BA01

ATC

diazepam; systemic, rectal

6.3

307.7

6571

6492

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

11744

39244

F43.00

ICD-10 Finland

Acute stress reaction mild

+∞

307.7

1032

N05BA02

ATC

chlordiazepoxide; systemic

23.5

307.7

1125

268

L12

ICPC

Hand/finger symptom/complaint

1.8

307.7

6448

20536

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

307.7

9004

30724

N06AX03

ATC

mianserin; oral

44.2

307.7

3142

418

R52.2

ICD-10 Finland

Other chronic pain

5.1

307.7

1591

1757

F41.1

ICD-10 Finland

Generalized anxiety disorder

+∞

307.7

3800

SPAT1241

SPAT

Extensive assessment of psychosocial situation

23.8

307.7

487

113

N05AX12

ATC

aripiprazole; systemic

765.5

307.7

955

F90.0

ICD-10 Finland

Disturbance of activity and attention

+∞

307.7

2037

IGY02

NOMESCO Finland

Psychiatric monitoring contact

56.3

307.7

1466

147

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

25.5

307.7

402

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

307.7

10221

32766

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

307.7

3723

9127

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

307.7

9987

36194

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

157.4

307.7

848

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

25668

111597

SPAT1310

SPAT

Counselling related to known health issue

1.8

307.7

11817

41766

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

+∞

307.7

532

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1015.2

307.7

1058

Z2446

NOMESCO Finland

Social worker

3.8

307.7

2554

3800

WX290

NOMESCO Finland

Other blockage of nerve

1.8

307.7

19368

74822

A02BC03

ATC

lansoprazole; oral

2.0

307.7

10831

33867

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

307.7

5054

13489

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

307.7

8611

25346

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

307.7

451

N06AA04

ATC

clomipramine; systemic

40.3

307.7

790

109

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

5.2

307.7

2301

2509

IHZ19, ,

SPAT

16.0

307.7

444

153

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

10.2

307.7

530

288

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

+∞

307.7

3977

N05AB03

ATC

perphenazine; systemic, rectal

51.9

307.7

1012

109

N05BA06

ATC

lorazepam; systemic, sublingual

7.5

307.7

1953

1479

N06AX17

ATC

milnacipran; oral

122.6

307.7

598

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

6403

19456

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

22346

90970

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

307.5

3584

9701

A97

ICPC

No disease

1.7

307.3

7411

25522

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

307.1

1995

4114

D09

ICPC

Nausea

3.0

304.6

1688

3178

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

303.9

11278

43317

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

+∞

303.6

374

J01FA06

ATC

roxithromycin; oral

1.5

300.4

14030

56702

R4110

NOMESCO Finland

Physiotherapy

1.6

300.2

9910

36998

R41.0

ICD-10 Finland

Disorientation, unspecified

4.9

299.4

849

962

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

299.1

2423

5594

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

+∞

297.9

367

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

+∞

297.9

367

K07.60

ICD-10 Finland

Snapping jaw

2.9

297.6

1757

3433

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.7

296.9

1932

3987

L86

ICPC

Back syndrome with radiating pain

2.5

296.0

2256

5055

J01FF01

ATC

clindamycin; systemic

1.6

295.8

9682

36049

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

294.8

36702

181991

IHZ01, ,

SPAT

8.4

291.9

522

341

OAA81, ,

SPAT

3.3

290.7

1343

2251

R03DC03

ATC

montelukast; oral

1.8

290.5

5749

18667

N05CD02

ATC

nitrazepam; oral

7.4

289.0

566

421

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

6.7

288.6

611

503

ICB01, ,

SPAT

24.1

288.0

324

L15

ICPC

Knee symptom/complaint

1.6

287.8

9171

33888

R03BB04

ATC

tiotropium bromide; inhalant

2.1

286.5

3381

9185

SPAT1229

SPAT

Assessment of need for aid

2.4

285.9

2326

5378

U04

ICPC

Incontinence urine

2.8

284.2

1736

3457

TAB00

NOMESCO Finland

Lumbar puncture

3.1

284.0

1491

2714

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

+∞

283.3

349

M01AH01

ATC

celecoxib; oral

1.8

283.2

6011

19915

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

282.9

5161

16331

A29

ICPC

General symptom/complaint other

1.9

282.7

4581

13951

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

13.5

282.5

390

159

N05AD03

ATC

melperone; systemic

17.9

282.1

348

107

W19

ICD-10 Finland

Unspecified fall

2.1

282.1

3468

9570

T82

ICPC

Obesity

3.0

282.0

1537

2863

U02

ICPC

Urinary frequency/urgency

1.8

280.8

5007

15728

R03BA02

ATC

budesonide; inhalant

1.7

280.6

6307

21238

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

+∞

279.2

344

R01AD08

ATC

fluticasone; nasal

1.6

279.1

10151

38666

A03FA02

ATC

cisapride; oral, rectal

2.3

278.8

2470

5942

ZXE00

NOMESCO Finland

One hour or less

1.5

278.7

13697

55735

R01AD12

ATC

fluticasone furoate; nasal

1.5

277.9

11471

44955

OAB91, ,

SPAT

2.3

277.9

2461

5919

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

277.6

6874

23772

IDY03, ,

SPAT

38.5

276.2

280

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

275.6

1516

2839

D06

ICPC

Abdominal pain localized other

2.1

275.5

3255

8842

A11

ICPC

Chest pain NOS

2.1

275.0

3024

7982

D82

ICPC

Teeth/gum disease

1.5

274.2

14167

58199

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

273.1

8731

32228

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

272.7

336

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

272.3

2176

4986

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

272.3

4757

14836

R96

ICPC

Asthma

2.0

271.8

3461

9672

D07AC01

ATC

betamethasone; topical

1.5

269.8

13226

53704

N89

ICPC

Migraine

3.4

269.1

1203

1971

S01.0

ICD-10 Finland

Open wound of scalp

2.2

268.1

2666

6746

Z00.0

ICD-10 Finland

General medical examination

1.7

267.9

6929

24219

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

267.4

14772

61430

J01FA10

ATC

azithromycin; systemic

1.4

267.3

21683

97089

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

374.8

266.5

341

R01AD58

ATC

fluticasone, combinations; nasal

1.6

265.8

9048

33871

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

53.9

264.8

255

S29

ICPC

Skin symptom/complaint other

1.6

264.7

7374

26270

R35

ICD-10 Finland

Polyuria

2.3

264.7

2395

5813

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

264.5

3501

9922

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

264.2

3077

8306

R13

ICD-10 Finland

Dysphagia

2.3

264.1

2373

5742

R00.2

ICD-10 Finland

Palpitations

2.2

263.5

2744

7079

A03

ICPC

Fever

1.7

262.2

6366

21863

R55

ICD-10 Finland

Syncope and collapse

2.0

262.2

3731

10852

Z12

ICPC

Relationship problem with partner

5.9

261.7

617

577

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

260.8

7695

27804

A02BA04

ATC

nizatidine; systemic

2.3

260.6

2452

6055

D10

ICPC

Vomiting

2.5

260.4

2019

4556

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

259.7

8454

31287

SPAT1237

SPAT

Psychotherapy

27.6

258.7

281

R06.5

ICD-10 Finland

Mouth breathing

2.0

258.1

3252

9045

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

257.9

4125

12486

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

254.1

8988

33896

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

124.6

254.1

227

ZXD05

NOMESCO Finland

Urgent procedure

1.5

253.7

10508

41056

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

253.7

4868

15610

A99

ICPC

Disease/condition unspecnature/site

2.0

252.7

3630

10586

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

252.4

7578

27472

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

5.7

251.4

611

591

M54.6

ICD-10 Finland

Pain in thoracic spine

2.2

251.3

2612

6729

SPAT1389

SPAT

Visit based on need for special support

4.9

250.7

710

803

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

250.2

4365

13584

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

+∞

249.9

308

OAA68, ,

SPAT

5.3

249.7

650

676

D19

ICPC

Teeth/gum symptom/complaint

1.5

249.6

11424

45566

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

249.2

18800

82631

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.1

248.9

2743

7237

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

+∞

248.3

306

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

248.3

306

AA400

NOMESCO Finland

Electroconvulsive therapy

434.1

248.1

316

SPAT1235

SPAT

Mental health, emotional support

31.2

247.1

261

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

246.7

304

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

245.9

10422

40871

IGP01

NOMESCO Finland

Psychiatric family contact

43.2

245.5

244

J01MA02

ATC

ciprofloxacin; systemic

1.5

245.5

13642

56549

N05BA05

ATC

potassium clorazepate; oral

15.2

244.8

321

116

F50.9

ICD-10 Finland

Eating disorder, unspecified

+∞

244.2

301

K08.3

ICD-10 Finland

Retained dental root

2.1

244.0

2748

7312

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.3

243.5

1147

1946

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

243.4

300

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

243.4

300

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

242.8

4676

14996

SPAT1227

SPAT

Substance abuse rehabilitation

29.6

242.5

259

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

242.3

26133

122257

I95.1

ICD-10 Finland

Orthostatic hypotension

3.2

241.1

1202

2116

SGA01

NOMESCO Finland

Emergency treatment

1.7

240.9

5900

20266

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

240.4

7457

27212

M01AX17

ATC

nimesulide; oral

1.6

240.2

7715

28390

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

238.1

7830

28968

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

237.8

1457

2903

R05

ICD-10 Finland

Cough

1.6

237.2

7577

27835

R4140

NOMESCO Finland

Psychotherapy

45.7

236.4

233

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.7

236.4

1606

3385

M02AA07

ATC

piroxicam; topical

1.5

236.4

11922

48393

R03AC03

ATC

terbutaline; inhalant

1.8

235.4

4670

15103

E66

ICD-10 Finland

Obesity

2.4

235.1

1931

4477

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

234.9

4678

15144

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.5

234.8

1020

1637

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

+∞

234.5

289

H01

ICPC

Ear pain/earache

1.8

233.3

4240

13349

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

232.8

4223

13287

J20

ICD-10 Finland

Acute bronchitis

1.9

232.1

3633

10897

309

Kela drug reimbursment

Nalmefene and naltrexone

104.2

231.3

209

SCA01

NOMESCO Finland

Preventive oral health care, short

1.5

231.0

10429

41350

S22.3

ICD-10 Finland

Fracture of rib

2.1

230.9

2541

6694

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

230.6

21647

98391

F41.01

ICD-10 Finland

Severe panic disorder

+∞

229.6

283

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

1536.5

228.9

285

R1250

NOMESCO Finland

Evaluation of functional capability

4.0

228.3

827

1159

R52.1

ICD-10 Finland

Chronic intractable pain

9.9

228.1

369

205

WX002

NOMESCO Finland

Sedation and analgesia

1.6

227.9

6268

22166

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

227.9

12876

53358

R4110, ,

SPAT

1.8

227.7

4641

15120

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

227.0

2995

8459

L13

ICPC

Hip symptom/complaint

1.6

226.2

6422

22889

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

225.6

278

G30

ICD-10 Finland

Alzheimer disease

56.2

224.5

215

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

224.3

7948

29866

P48

ICPC

Psychological, Clarification/discussion RFE/demand

21.6

224.3

260

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

223.0

4731

15586

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.1

222.6

2546

6809

WYA10

NOMESCO Finland

Emergency care or similar visit

2.1

220.8

2493

6632

V03AB30, ,

ATC

16.8

220.3

278

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

219.9

271

A02BC04

ATC

rabeprazole; oral

2.0

219.3

2893

8167

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

218.8

1825

4259

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

218.8

2574

6959

Z06

ICPC

Unemployment problem

9.1

218.5

372

225

R03BA05

ATC

fluticasone; inhalant

1.6

218.0

6175

21977

G43

ICD-10 Finland

Migraine

2.5

217.7

1653

3687

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

217.2

1987

4837

N03AF02

ATC

oxcarbazepine; oral

3.2

216.3

1070

1873

M03BX01

ATC

baclofen; systemic

4.7

215.9

630

733

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

215.8

9470

37234

C03CA01

ATC

furosemide; systemic

1.5

215.6

9408

36945

A06AC51

ATC

ispaghula, combinations; oral

2.6

215.5

1556

3383

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

214.6

3660

11278

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.7

214.4

1373

2802

IDY99, ,

SPAT

41.9

214.3

214

U07

ICPC

Urine symptom/complaint other

2.0

213.3

2779

7806

SPAT1360

SPAT

Extensive global examination

2.2

213.3

2235

5767

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

213.1

8366

32111

U01

ICPC

Dysuria/painful urination

2.0

212.6

2620

7208

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.2

212.3

478

424

G43.3

ICD-10 Finland

Complicated migraine

5.3

211.9

547

564

L16

ICPC

Ankle symptom/complaint

1.8

211.8

4166

13412

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

53.3

211.6

204

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

211.4

8211

31435

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

+∞

210.9

260

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

+∞

210.9

260

N76.0

ICD-10 Finland

Acute vaginitis

2.3

210.8

1937

4724

K04.0

ICD-10 Finland

Pulpitis

1.9

209.8

3133

9236

K08.80

ICD-10 Finland

Toothache NOS

1.9

208.9

3053

8932

R03BA01

ATC

beclometasone; inhalant

1.7

208.8

4607

15329

SDA03

NOMESCO Finland

Periodontal treatment

1.4

208.7

15055

64973

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

208.4

5592

19609

N05CD08

ATC

midazolam; nasal, systemic

4.2

208.4

690

898

F84.5

ICD-10 Finland

Asperger syndrome

+∞

207.7

256

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

207.4

3744

11739

K04.08

ICD-10 Finland

Other specified pulpit

2.0

206.1

2742

7758

F01.9

ICD-10 Finland

Vascular dementia, unspecified

+∞

206.1

254

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

205.9

9907

39626

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.5

205.6

1601

3614

G04BD08

ATC

solifenacin; oral

2.3

205.0

1965

4881

T90

ICPC

Diabetes non-insulin dependent

1.5

204.6

8109

31151

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

204.2

1767

4193

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

204.2

1617

3680

R83

ICPC

Respiratory infection other

1.5

203.1

9226

36460

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

201.7

1495

3293

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

201.3

5349

18696

D12

ICPC

Constipation

2.9

201.2

1176

2279

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

201.0

3585

11192

R5110, ,

SPAT

2.0

201.0

2691

7629

Z01.7

ICD-10 Finland

Laboratory examination

1.6

200.9

5767

20553

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

200.5

1566

3539

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

199.3

2386

6488

R12

ICD-10 Finland

Heartburn

1.9

199.0

2874

8369

R50.9

ICD-10 Finland

Fever, unspecified

1.6

199.0

5195

18072

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

11.2

198.8

300

147

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

22.0

198.7

229

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

198.7

1031

1860

C08CA01

ATC

amlodipine; oral

1.4

198.4

13005

55054

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

198.1

1478

3266

WX723

NOMESCO Finland

CPAP therapy

2.4

198.0

1654

3860

A01AB09

ATC

miconazole; local oral

2.0

197.8

2690

7668

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

20.8

196.9

231

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

196.8

10570

43125

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

+∞

196.3

242

SPAT1252

SPAT

Overall medication plan or its review

2.2

195.9

1947

4910

SPAT1247

SPAT

Outpatient detoxication and monitoring

35.6

195.5

201

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

194.2

3053

9148

IHZ07, ,

SPAT

17.1

194.0

243

P28

ICPC

Limited function/disability (P)

24.3

193.5

217

Z72.0

ICD-10 Finland

Tobacco use

3.4

193.3

862

1408

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

9.7

193.2

316

179

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

192.5

6064

22084

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

+∞

192.2

237

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

191.4

236

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

191.4

2455

6848

IGV01

NOMESCO Finland

Psychiatric network contact

661.2

191.2

241

R60.0

ICD-10 Finland

Localized oedema

1.7

191.1

4042

13268

P19

ICPC

Drug abuse

12.3

190.8

275

123

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

+∞

189.8

234

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

189.6

6476

24024

L29

ICPC

Musculoskeletal sympt/complt other

1.9

189.5

2977

8915

SPAT1058

SPAT

PEF monitoring instruction

2.0

188.8

2573

7336

R07.0

ICD-10 Finland

Pain in throat

2.0

188.7

2492

7025

P18

ICPC

Medication abuse

28.5

188.5

203

WZC00, ,

SPAT

1.6

188.2

5281

18689

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

188.1

3228

9947

R25.1

ICD-10 Finland

Tremor, unspecified

3.1

188.1

981

1775

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

187.7

3277

10153

SPAT1281

SPAT

Other administrative function

2.0

187.5

2510

7111

M01AH02

ATC

rofecoxib; oral

1.7

187.2

3902

12751

E66.9

ICD-10 Finland

Obesity, unspecified

2.7

186.1

1181

2396

Z63.4

ICD-10 Finland

Disappearance and death of family member

7.9

186.1

347

241

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

185.4

4006

13223

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

+∞

184.9

228

WX780

NOMESCO Finland

Remote monitoring CPAP

2.3

184.5

1645

3954

R63.4

ICD-10 Finland

Abnormal weight loss

2.6

183.7

1315

2844

X58

ICD-10 Finland

Exposure to other specified factors

1.6

183.3

5312

18940

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

183.0

2122

5694

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

182.5

7848

30572

D02

ICPC

Abdominal pain epigastric

2.1

182.3

2115

5677

IHZ05

NOMESCO Finland

Therapeutic conversation

24.7

181.9

203

M54.8

ICD-10 Finland

Other dorsalgia

2.4

181.7

1524

3561

M54.3

ICD-10 Finland

Sciatica

2.2

181.2

1937

5032

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

+∞

180.9

223

R06AX22

ATC

ebastine; oral

1.6

180.4

5652

20528

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

180.2

1420

3221

A98

ICPC

Health maint/preventive medicine

1.8

180.2

40257

209303

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

180.1

2290

6364

X15

ICPC

Vaginal symptom/complaint other

2.6

180.0

1216

2552

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

179.6

4060

13565

H02AB04

ATC

methylprednisolone; systemic

1.6

179.3

4699

16330

Z63.5

ICD-10 Finland

Disruption of family by separation and divorce

33.1

179.3

187

M54.1

ICD-10 Finland

Radiculopathy

2.5

178.9

1314

2879

A10BA02

ATC

metformin; oral

1.4

178.5

9291

37559

N05AD01

ATC

haloperidol; systemic

4.1

178.5

618

835

D07AA02

ATC

hydrocortisone; topical

1.6

178.2

4652

16148

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(36660697) Celiac disease serology panel - Serum

4473

12973

1.99

320.25

1.2

—

(4198724) Urine methamphetamine measurement

375

102

20.24

316.68

2.8

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

11180

42672

1.58

310.72

4.2

3.4

0.33

0.24

0.27

457

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6040

19592

1.80

307.72

2.9

7.90

9.60

umol/l

6.27

5159

17594

(3013650) Neutrophils [#/volume] in Blood by Automated count

25426

102991

1.86

307.65

8.7

9.5

4.14

4.08

e9/l

4.05

22044

89204

(3021960) Folate [Moles/volume] in Serum or Plasma

14899

40403

2.55

307.65

1.8

1.6

20.29

19.87

nmol/l

2.51

12823

34183

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16451

58062

1.89

307.65

3.6

3.2

33.87

33.93

u/l

0.02

15383

55123

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

32171

131347

2.36

307.65

4.9

4.2

11.55

11.67

mm/h

0.79

30185

123460

(3023103) Potassium [Moles/volume] in Serum or Plasma

39565

187305

3.02

307.65

22.4

16.1

3.96

3.97

mmol/l

32.26

38851

182892

(3013826) Glucose [Moles/volume] in Serum or Plasma

26013

103801

1.94

307.65

5.8

4.8

6.67

6.72

mmol/l

3.35

24716

97360

(3037467) Urinalysis macro (dipstick) panel - Urine

29216

123676

1.91

307.65

5.1

4.1

2.13

2.37

0.22

212

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3590

3945

5.33

307.65

1.9

1.3

0.35

0.23

mg/l

20.12

1854

1658

(42870588) Differential panel, method unspecified - Blood

16045

59626

1.75

307.65

6.4

6.7

5.27

5.98

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40143

200518

2.49

307.65

14.1

10.9

27.59

26.66

u/l

13.26

39139

194970

(3048689) Calprotectin [Mass/mass] in Stool

7316

20821

2.11

307.65

2.4

2.8

125.80

143.37

ug/g

2.85

5776

16986

(3027008) Opiates [Presence] in Urine

3038

5622

3.10

307.65

2.1

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10675

37078

1.76

307.65

1.9

1.8

1.06

1.35

mg/l

14.41

8093

29069

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8534

29139

1.75

307.65

1.4

1.3

9.01

13.48

u/ml

6.63

3223

11652

(3019069) Monocytes/Leukocytes in Blood

21360

84563

1.76

307.65

6.7

8.73

8.93

18.60

20013

79905

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

37426

176431

2.26

307.65

5.6

4.6

5.98

5.88

mmol/l

35.51

34586

163543

(3033658) Prothrombin time (PT) actual/Normal

11989

45041

1.63

307.65

4.7

4.0

91.26

88.94

18.77

11695

44184

(3032080) INR in Blood by Coagulation assay

20367

80661

1.72

307.65

14.7

14.5

1.22

1.26

inr

27.24

17134

67040

(3006315) Basophils [#/volume] in Blood

23421

91643

1.87

307.65

6.4

6.3

0.04

e9/l

2.56

20174

79013

(3035350) Ketones [Presence] in Urine by Test strip

23441

96808

1.71

307.65

4.3

3.5

4.59

3.42

estimate

0.45

5186

19649

(3001122) Ferritin [Mass/volume] in Serum or Plasma

23101

82092

2.16

307.65

3.5

2.9

115.37

134.94

ug/l

16.58

21476

77317

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9241

31585

1.76

307.65

1.4

1.3

30.82

37.97

iu/ml

3.16

2617

10050

(3000850) Epithelial cells [#/volume] in Urine

10703

38430

1.69

307.65

3.0

2.7

5.54

4.92

e6/l

4.05

9742

35011

(3023368) Bacteria identified in Blood by Culture

12679

46528

1.69

307.65

4.8

4.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

28340

115334

2.01

307.65

5.5

3.9

1234.92

1255.78

e6/l

0.02

362

1587

(3009261) Glucose [Presence] in Urine by Test strip

23498

97704

1.69

307.65

4.4

3.5

0.23

0.34

estimate

0.19

4906

18559

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

15238

49024

2.08

307.65

2.4

2.0

204.68

195.05

u/l

0.36

14410

46323

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

21264

73042

2.17

307.65

7.1

6.9

1.21

mmol/l

1.26

19726

67955

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

15968

52453

2.06

307.65

3.1

2.6

59.13

63.50

u/l

1.80

14734

49050

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7696

25312

1.80

307.65

2.7

2.8

22.55

22.97

1.68

7055

23854

(36304419) Bacteria [Presence] in Urine

12789

46041

1.74

307.65

3.6

3.1

26.62

114.56

estimate

0.62

216

(3019550) Sodium [Moles/volume] in Serum or Plasma

39530

186782

3.03

307.65

22.2

15.9

139.54

139.76

mmol/l

55.34

38868

182760

(3020191) Ethanol [Moles/volume] in Serum or Plasma

765

585

7.25

307.65

1.5

1.1

1.59

0.70

promille

29.05

587

481

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21592

75391

2.14

307.65

2.7

2.3

4263.04

77.58

nmol/l

0.50

19584

69048

(3026782) Osmolality of Urine

9078

32433

1.67

307.65

3.2

2.9

520.30

552.28

mosm/kgh2o

31.97

7970

28706

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

24416

90659

2.09

307.65

6.6

7.0

10.96

12.03

umol/l

27.50

23155

86845

(3002582) Erythrocytes [#/volume] in Urine

15207

56797

1.72

307.65

3.8

3.3

60.03

94.82

e6/l

2.31

11615

43174

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

13401

41579

2.11

307.65

2.5

2.3

2.77

2.87

mg/l

4.31

11534

36213

(3016879) Cocaine [Presence] in Urine

2912

4950

3.37

307.65

2.2

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

21291

74758

2.10

307.65

5.2

5.4

36.12

35.70

g/l

21.46

19954

70614

(3027944) Amphetamines [Presence] in Urine

2984

5636

3.03

307.65

2.1

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

10712

33764

1.98

307.65

1.5

2.42

2.41

g/l

0.21

6444

21808

(3030467) Casts [#/volume] in Urine by Automated count

13380

48677

1.73

307.65

3.6

3.2

0.37

0.41

e6/l

1.42

9868

35423

(3021601) Nitrite [Presence] in Urine by Test strip

23206

95643

1.71

307.65

4.3

3.5

0.00

estimate

0.28

5103

19237

(3018418) pH of Serum or Plasma

14469

47825

1.98

307.65

4.4

4.7

7.40

0.64

10362

33927

(3019198) Lymphocytes [#/volume] in Blood

23788

93713

1.87

307.65

6.5

6.3

1.95

1.91

e9/l

2.44

20991

82744

(3002030) Lymphocytes/Leukocytes in Blood

21774

87165

1.74

307.65

6.6

6.5

28.14

27.85

3.26

20596

83155

(1001926) Buprenorphine [Presence] in Urine by Screen method

2581

3624

4.07

307.65

2.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6766

22181

1.79

307.65

6.2

6.9

1.03

1.04

mmol/l

1.89

6323

20767

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5152

15508

1.92

307.65

2.5

2.4

0.21

g/l

3.73

4731

14656

(3028707) Methadone [Presence] in Urine by Screen method

1829

323

32.25

307.65

2.5

1.2

—

(3028300) Cannabinoids [Presence] in Urine

3056

5645

3.11

307.65

2.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39029

186429

2.62

307.65

19.5

13.5

22.20

25.46

mg/l

67.22

33209

149156

(3019309) Folate [Moles/volume] in Red Blood Cells

9240

21136

2.77

307.65

1.8

1.7

1168.77

1123.00

nmol/l

4.15

6968

16063

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17362

63226

1.84

307.65

4.4

3.3

57.66

62.10

ng/l

0.15

11780

43314

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9995

29228

2.13

307.65

2.8

3.3

2.44

2.45

mmol/l

10.30

8925

26306

(3021589) Normoblasts [#/volume] in Blood

19742

82306

1.57

307.65

12.4

10.8

0.00

e9/l

1.32

16078

67618

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6202

17314

2.12

307.65

2.4

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6018

19047

1.84

307.65

1.9

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8634

27390

1.90

307.65

3.5

3.8

0.81

0.82

mmol/l

9.10

8078

26014

(40768797) Stomach Pathology biopsy report

7321

22237

1.96

307.65

1.3

1.2

—

(3022096) Basophils/Leukocytes in Blood

21284

84425

1.75

307.65

6.7

6.6

0.69

0.68

2.43

19915

79665

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5939

13244

2.68

307.65

2.2

2.6

372.22

382.02

nmol/l

2.66

5427

12511

(3037522) Nuclear Ab [Titer] in Serum

7285

24267

1.77

307.65

1.4

445.97

560.88

titre

6.14

1461

5240

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5238

15344

1.98

307.65

2.9

2.5

44.47

55.77

u/l

0.46

4400

13184

(3044889) 12 lead EKG panel

28497

124897

1.73

307.65

4.3

3.7

7924.10

1969.45

0.45

251

(3022948) Iron [Moles/volume] in Serum or Plasma

8937

29174

1.85

307.65

2.7

13.33

13.26

umol/l

0.38

8242

27550

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8019

26125

1.83

307.65

2.1

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

16848

53643

2.18

307.65

3.1

4.0

2.35

mmol/l

0.56

15311

49074

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8304

27223

1.83

307.65

2.7

2.37

2.32

g/l

10.15

7557

25499

(3009508) Creatinine [Moles/volume] in Urine

15769

63103

1.58

307.65

3.6

3.5

7.85

7.87

mmol/l

0.15

13302

54085

(3000764) Benzodiazepines [Presence] in Urine

3043

5548

3.15

307.65

2.2

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6648

19206

2.05

307.65

2.5

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10447

30479

2.15

307.65

1.8

1.7

29539604.11

44391279.45

pmol/l

1.48

8680

25503

(3013115) Eosinophils [#/volume] in Blood

24011

94504

1.88

307.65

6.6

6.4

0.19

e9/l

0.24

21048

82713

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

34519

133348

3.13

307.65

5.0

3.9

14.61

14.82

pmol/l

45.96

31866

122494

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

33195

136122

2.47

307.65

9.0

8.3

78.09

79.61

u/l

6.18

31574

129738

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13128

50173

1.62

307.65

3.3

3.2

1131.86

1422.28

ng/l

11.17

11020

43645

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

637

67.87

307.65

2.0

1.5

—

(3001604) Monocytes [#/volume] in Blood

23348

91419

1.87

307.65

6.4

6.3

0.58

0.59

e9/l

2.44

20099

78824

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8611

15644

3.51

307.65

2.0

1.4

1.56

1.30

133.91

7451

13998

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

30193

124806

2.09

307.65

4.1

2.8

51.91

45.74

u/l

19.83

28460

118196

(3029937) Albumin [Presence] in Urine by Test strip

13280

51815

1.58

307.65

4.6

3.6

0.00

estimate

1.23

4797

17586

(3011288) Drugs identified in Urine by Screen method Nominal

2554

2444

6.00

307.65

3.1

1.2

—

(3018095) Leukocytes [#/volume] in Urine

17159

65803

1.71

307.65

4.5

3.8

71.80

98.78

e6/l

4.56

12179

45783

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

36658

173926

2.05

307.65

7.0

5.8

39.29

39.03

mmol/mol

5.76

34382

163879

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

23363

82316

2.21

307.65

7.6

1.21

mmol/l

0.11

20211

71395

(3015736) pH of Urine

19331

75528

1.72

307.65

3.7

3.1

6.23

6.19

6.66

10564

42684

(3020564) Creatinine [Moles/volume] in Serum or Plasma

40416

201167

2.73

307.65

24.3

17.7

76.81

78.47

umol/l

17.25

39995

198752

(3018010) Neutrophils/Leukocytes in Blood

21373

85344

1.73

307.65

6.5

6.4

56.99

57.21

1.83

20382

82016

(3006504) Eosinophils/Leukocytes in Blood

21314

84335

1.76

307.65

6.6

2.86

2.88

0.42

19970

79648

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

37395

178931

2.11

307.65

18.0

13.7

84.66

81.67

ml/min/173m2

132.71

34756

163240

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

38202

165612

3.41

307.65

6.3

4.5

1.80

1.95

mu/l

66.06

35875

153280

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

16628

62271

1.75

307.65

3.8

3.3

2.51

2.10

e6/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12325

38084

2.08

307.65

1.4

1.3

1.53

1.99

u/ml

2.79

3302

10624

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

21698

69550

2.43

307.65

2.3

1.9

96.85

95.73

pmol/l

2.47

11834

37084

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5645

17947

1.83

306.77

2.0

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

17307

73103

1.49

300.22

4.3

3.4

0.52

0.47

estimate

0.07

4271

15786

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

488

275

9.79

299.21

1.0

35.83

29.80

ng/l

2.00

344

185

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

486

274

9.78

297.91

1.0

821.77

878.54

ng/l

0.79

337

185

(40758558) Short blood count panel - Blood

13385

53630

1.53

297.55

6.1

6.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

484

276

9.67

294.69

1.0

274.24

424.79

ng/l

0.55

345

190

(3019150) Specific gravity of Urine by Refractometry

10753

41134

1.57

292.73

4.4

3.6

1.16

1.09

kg/l

0.18

7127

26975

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8871

32402

1.62

292.42

4.4

3.6

241.96

688.95

ng/l

18.25

6623

25302

(46235355) HIV 1 and 2 tests - Meaningful Use set

9555

35587

1.60

290.78

2.1

1.9

—

(3013512) EKG study

14614

59899

1.50

290.28

3.9

3.4

0.74

0.75

0.08

154

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3273

8755

2.13

288.52

2.3

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3813

10839

2.01

286.76

2.4

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3913

11248

1.99

285.35

1.7

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

8399

30599

1.62

277.70

3.2

2.9

0.97

1.03

e6/l

0.81

4394

16368

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5168

16468

1.81

276.57

2.7

2.1

13.39

13.15

nmol/l

1.13

4621

15173

(3007461) Platelets [#/volume] in Blood

40880

210772

2.30

271.30

28.8

20.1

255.35

248.97

e9/l

70.92

40213

206005

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1933

4215

2.57

267.10

1.5

1.4

271.79

264.06

ug/g

0.58

1100

2530

(3024731) MCV [Entitic mean volume] in Red Blood Cells

40882

210917

2.29

266.90

28.7

20.0

91.06

90.72

41.61

40527

208727

(3035941) MCH [Entitic mass]

40881

210911

2.29

266.86

28.7

20.0

30.35

30.25

26.02

40527

208732

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

40883

210929

2.29

266.74

29.3

20.5

40.62

41.54

6.40

40523

208607

(3023183) Ammonium ion [Moles/volume] in Plasma

1412

2585

3.05

266.32

3.2

2.5

34.08

34.71

umol/l

0.27

1275

2355

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3661

10531

1.98

265.52

3.6

3.7

5.19

5.09

kpa

10.24

3493

10058

(3026361) Erythrocytes [#/volume] in Blood

40881

210951

2.28

265.51

28.7

20.0

4.50

4.55

e12/l

57.34

40088

205446

(3010813) Leukocytes [#/volume] in Blood

40886

210994

2.29

265.30

28.8

20.1

6.83

6.65

e9/l

37.57

40109

205477

(3000963) Hemoglobin [Mass/volume] in Blood

40883

211032

2.28

263.28

29.0

20.2

135.61

136.68

g/l

39.85

40531

208874

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1595

3167

2.82

262.19

1.3

1.4

505.66

568.05

mg/l

2.60

1518

3065

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3485

9916

2.00

260.24

3.2

3.9

4.47

4.55

pmol/l

4.06

3083

9155

(3009343) pH of Capillary blood

3561

10228

1.98

259.05

3.6

3.7

7.41

7.42

2.31

2973

8466

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

447

278

8.86

258.03

2.0

1.2

154.48

64.80

umol/l

5.08

244

123

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1458

2782

2.93

256.68

1.5

1241.22

2088.85

e6/l

0.48

1152

2172

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1442

2742

2.94

255.33

1.4

1.5

20.14

43.40

e6/l

1.91

1061

2020

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1885

4182

2.53

251.46

2.2

1.7

202.12

203.06

pmol/l

0.12

1771

4015

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2323

5732

2.28

247.01

2.1

1.7

38.76

42.43

nmol/l

9.39

2263

5622

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7684

28147

1.60

244.36

3.4

3.0

2.68

2.49

e6/l

0.65

3657

13888

(3021387) Prolactin [Units/volume] in Serum or Plasma

2158

5181

2.34

243.87

1.7

284.05

277.80

mu/l

0.28

1946

4811

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3152

8856

2.02

242.91

3.4

3.6

1.61

1.62

mmol/l

0.08

2350

6430

(3014111) Lactate [Moles/volume] in Serum or Plasma

4661

14935

1.79

242.74

7.8

8.4

1.38

1.31

mmol/l

3.50

4553

14693

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

37775

190988

1.68

234.81

6.1

5.3

2.72

2.75

mmol/l

8.26

35243

179731

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1415

2795

2.82

234.44

1.2

1.3

3.79

3.68

mmol/l

2.81

1327

2663

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

4116

12846

1.83

232.80

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

6115

21431

1.65

230.52

1.7

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5489

18756

1.69

227.37

7.5

6.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

2016

4859

2.33

225.50

1.5

1.4

9.06

9.78

u/l

1.42

1590

3998

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7232

26667

1.58

221.00

2.1

2.3

29.54

29.72

1.53

7034

25989

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4978

16736

1.71

218.07

4.2

4.1

5.86

5.79

kpa

4.78

4829

16386

(3019225) pH of Specimen

4527

14899

1.74

213.55

4.2

4.3

7.36

0.21

3256

10849

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

37303

188884

1.61

211.68

5.4

4.8

4.61

4.66

mmol/l

14.46

34942

178544

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2083

5237

2.23

211.38

2.2

2.4

518.64

616.38

ug/l

0.35

1962

4976

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

32506

159913

1.46

210.47

22.4

16.5

13.60

13.55

10.90

32125

157631

(3002032) Base excess in Venous blood by calculation

4831

16356

1.69

205.42

4.2

4.1

1.69

mmol/l

0.01

4287

14378

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

35515

178102

1.52

205.09

4.5

4.0

1.38

1.25

mmol/l

148.23

32705

166324

(3027801) Oxygen [Partial pressure] in Arterial blood

5575

19613

1.63

204.89

8.2

8.1

12.04

12.90

kpa

26.17

5388

18857

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5575

19619

1.63

204.62

8.2

8.1

5.12

5.06

kpa

4.74

5392

18863

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19634

88874

1.38

203.69

2.9

2.8

—

estimate

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37085

187858

1.58

203.18

5.3

4.7

1.41

1.46

mmol/l

86.29

34528

176646

(3012544) pH of Venous blood

4995

17118

1.67

202.85

4.3

4.2

7.38

0.16

2836

10224

(3019977) pH of Arterial blood

5559

19639

1.63

200.57

8.3

8.1

7.42

0.57

3022

10300

(3023323) Follitropin [Units/volume] in Serum or Plasma

2619

7360

2.00

200.39

1.4

1.3

24.39

28.26

iu/l

6.57

2205

6375

(3044290) Cell count panel - Cerebral spinal fluid

1309

2700

2.70

200.28

1.5

1.4

—

(3003396) Base excess in Arterial blood by calculation

5521

19479

1.63

200.22

8.2

8.1

0.89

0.75

mmol/l

1.73

4641

16069

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3039

9003

1.91

200.19

1.9

1.6

—

(3042936) Bacteria identified in Isolate by Culture

6765

25091

1.56

199.25

2.2

2.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2792

8054

1.95

198.58

1.1

18.71

5.00

u/ml

0.63

(3024354) Oxygen [Partial pressure] in Venous blood

4189

13753

1.73

198.38

3.6

3.3

4.61

4.57

kpa

0.44

4055

13428

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2871

8400

1.93

195.99

1.1

1.0

—

(3000494) Fungus identified in Specimen by Culture

5900

21277

1.60

195.39

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

2960

8763

1.91

195.19

1.3

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3137

9493

1.87

193.61

4.2

4.5

24.16

24.11

mmol/l

0.35

3085

9408

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10962

45233

1.43

191.04

2.5

2.4

—

(3022145) Colonoscopy Study observation

5681

20515

1.59

186.27

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

3545

11279

1.78

186.19

1.4

1.3

289.43

246.12

u/ml

0.67

3284

10572

(3027945) Reticulocytes/Erythrocytes in Blood

5503

19773

1.60

184.03

2.5

2.7

1.80

1.74

3.83

4826

17924

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3798

12373

1.74

184.01

4.2

4.1

1.22

1.23

mmol/l

1.20

3230

10862

(3016502) Oxygen saturation in Arterial blood

4983

17534

1.62

181.18

8.6

8.5

95.51

95.80

2.34

4846

16889

(3026493) Urate [Moles/volume] in Serum or Plasma

11696

49241

1.41

180.10

2.7

2.8

339.89

346.90

umol/l

10.16

10169

44291

(3005719) IgG [Mass/volume] in Serum or Plasma

4067

13611

1.70

178.80

2.7

3.0

10.45

10.72

g/l

3.28

3718

12705

(3013139) Helicobacter pylori Ag [Presence] in Stool

3513

11313

1.76

176.73

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

12377

52764

1.39

176.46

3.6

3.0

0.30

0.25

estimate

0.13

4185

15161

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3514

11362

1.75

174.24

8.1

8.7

24.85

24.65

mmol/l

2.50

3488

11299

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2057

5576

2.06

172.61

3.7

3.9

24.87

24.69

mmol/l

1.95

1899

5167

(3014051) Protein [Presence] in Urine by Test strip

12320

52704

1.39

170.78

3.1

2.7

0.12

0.06

1.13

218

1230

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3968

13376

1.68

169.37

2.5

2.2

6.83

8.50

ug/l

3.83

3355

12074

(3012516) Albumin [Mass/volume] in Urine

13811

60268

1.37

169.25

3.6

50.41

49.11

mg/l

0.24

8913

38779

(3003327) Ova and parasites identified in Stool by Light microscopy

2054

5661

2.03

164.81

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

13965

61292

1.36

163.58

4.4

4.3

9.37

8.37

mg/mmol

1.34

8680

38754

(3003181) Sodium [Moles/volume] in Urine

1099

2302

2.65

163.13

1.5

1.3

60.04

63.21

mmol/l

1.40

855

1879

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3509

11552

1.72

162.87

1.2

126.62

156.60

u/ml

3.40

1267

4530

(3020961) Endomysium IgA Ab [Titer] in Serum

2591

7815

1.86

160.47

1.1

148.48

190.43

titre

0.47

277

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3698

12425

1.68

159.24

3.9

4.4

89.51

94.10

ng/l

1.73

3176

10972

(3045414) Leukocytes [Presence] in Urine

4637

16526

1.60

158.56

2.1

2.0

0.03

0.02

estimate

0.15

979

3573

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3556

11911

1.69

154.66

2.4

20.39

21.35

au/ml

0.25

298

1444

(3017732) Neutrophils [#/volume] in Blood

5921

22485

1.51

152.44

2.8

3.0

4.58

4.48

e9/l

0.34

5022

19723

(3009466) Valproate [Moles/volume] in Serum or Plasma

469

582

4.44

149.71

3.3

2.7

333.51

357.50

umol/l

1.92

395

473

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2153

6277

1.92

147.28

1.3

1.2

0.63

0.91

u/ml

0.64

169

464

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3291

10933

1.70

147.17

1.3

41.91

56.14

au/ml

2.79

152

763

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4576

16530

1.57

147.08

9.1

9.0

122.79

121.41

g/l

4.04

4493

16115

(3014765) Yersinia sp identified in Stool by Organism specific culture

1559

4040

2.15

146.21

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1557

4056

2.14

144.12

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1545

4021

2.14

143.33

1.2

1.1

—

(3020891) Body temperature

2385

7261

1.84

143.03

5.2

4.3

36.93

36.89

°c

4.49

2363

7200

(3028026) IgM [Mass/volume] in Serum or Plasma

3187

10609

1.69

141.22

1.9

2.0

1.31

1.29

g/l

0.15

2921

9862

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

17204

79208

1.31

138.44

2.0

1.9

1.46

1.31

mmol/l

69.89

14400

67126

(3000492) Spirometry study

4921

18311

1.53

138.11

1.6

1.5

—

18.97

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2063

6065

1.90

137.49

1.6

1.7

16.24

18.48

u/ml

0.52

402

1635

(40761536) Microorganisms panel - Urine sediment

3863

13641

1.60

135.91

4.6

3.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1912

5581

1.91

130.00

2.8

3.1

24.76

24.45

mmol/l

2.94

1876

5485

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3275

11221

1.64

129.68

10.2

10.3

1.41

1.24

17.97

3266

11147

(3023520) Reticulocytes [#/volume] in Blood

4178

15186

1.56

129.67

2.5

2.8

71.23

68.63

e9/l

4.15

3004

11210

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1589

4347

2.03

129.52

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3992

14403

1.57

127.84

2.4

2.9

66.64

66.43

g/l

0.93

3629

13421

(3019060) Gas panel - Arterial blood

2860

9497

1.69

127.36

5.1

4.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1634

4558

1.99

126.31

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4508

16765

1.52

126.00

3.9

3.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3045

10318

1.66

125.66

9.8

10.3

24.25

24.15

mmol/l

0.83

2971

10133

(3004588) Protein electrophoresis panel - Serum or Plasma

3258

11280

1.62

123.56

2.3

2.6

—

2.00

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3166

10900

1.63

122.73

10.5

10.6

0.64

0.63

0.28

3157

10842

(3020779) Urea [Moles/volume] in Serum or Plasma

4320

16066

1.52

120.37

7.9

8.5

9.10

10.30

mmol/l

22.57

4126

15390

(3023410) Appearance of Cerebral spinal fluid

675

1285

2.90

118.86

1.6

1.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2567

8483

1.69

115.99

3.4

2.9

1.36

1.14

17.46

2559

8437

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7597

31650

1.38

115.31

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2546

8438

1.69

113.76

3.4

2.9

0.63

0.62

0.72

2541

8408

(3023511) Choriogonadotropin [Units/volume] in Urine

983

2346

2.32

111.53

1.3

1.2

—

(3010421) pH of Blood

1663

4877

1.90

111.23

4.0

3.4

7.41

0.60

1641

4820

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

739

1542

2.64

110.37

1.5

1.7

305.92

345.69

mu/l

1.09

572

1292

(3007566) Smooth muscle Ab [Titer] in Serum

1637

4829

1.88

107.54

1.2

1.3

92.88

137.78

titre

1.88

170

460

(3006653) Thiamine [Moles/volume] in Blood

378

526

3.95

105.35

1.3

1.2

140.08

135.94

nmol/l

0.73

378

526

(3008295) Osmolality of Serum or Plasma

654

1312

2.75

105.05

1.6

1.4

277.32

279.27

mosm/kgh2o

1.08

478

1044

(3034770) Mitochondria Ab [Titer] in Serum

1600

4764

1.87

102.11

1.2

1.3

609.25

1112.59

titre

2.83

147

(1616796) Gas panel - Central venous blood

1252

3438

2.02

100.77

3.9

3.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2444

8289

1.65

99.73

1.3

1.5

—

(3008898) HLA-B27 [Presence]

1854

5844

1.76

98.50

1.1

—

(3012501) Base excess in Blood by calculation

1173

3175

2.05

98.10

4.2

3.7

2.33

2.45

mmol/l

0.72

817

2093

(3013290) Carbon dioxide [Partial pressure] in Blood

1173

3176

2.04

98.01

4.2

3.7

5.02

4.94

kpa

2.55

1147

3113

(3027315) Oxygen [Partial pressure] in Blood

1176

3205

2.03

96.57

4.3

3.7

8.77

8.67

kpa

0.97

1150

3142

(3019832) Treponema pallidum Ab [Presence] in Serum

4961

19788

1.42

95.23

1.9

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1088

2905

2.07

94.28

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2202

7377

1.66

94.03

1.9

1.8

8.14

7.53

iu/ml

0.28

518

1741

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1087

2905

2.07

93.97

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

847

2058

2.27

92.27

1.4

1.3

25.88

28.06

u/l

0.95

672

1771

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3890

14927

1.46

91.57

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

1161

3222

1.99

90.74

2.8

2.5

16.74

16.56

1.03

1133

3144

(3025159) Blasts/Leukocytes in Blood

4062

15768

1.45

89.99

4.2

4.8

0.06

0.42

6.82

993

4294

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2814

10131

1.55

89.48

7.7

6.8

24.61

24.40

mmol/l

2.15

2724

9635

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1864

6049

1.71

89.38

2.4

5963.82

6272.92

u/l

0.13

664

2781

(3018405) Lactate [Moles/volume] in Arterial blood

1594

4942

1.79

89.35

4.5

4.0

1.37

1.39

mmol/l

0.29

1578

4826

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5330

21755

1.39

89.06

4.0

5.1

232.94

248.73

u/l

10.18

5020

20889

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

548

1098

2.75

88.26

2.2

2.4

19.37

18.50

nmol/l

1.06

506

1048

(3028271) Lactate [Moles/volume] in Capillary blood

887

2253

2.17

87.07

1.9

1.7

1.75

1.70

mmol/l

0.68

859

2175

(3004119) Hemoglobin [Mass/volume] in Venous blood

2881

10490

1.54

87.03

3.7

3.4

130.64

129.16

g/l

2.64

2773

10225

(3002179) Metamyelocytes/Leukocytes in Blood

3987

15520

1.44

86.86

3.9

4.4

0.61

0.72

1.77

1155

4846

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1827

5961

1.70

85.87

2.4

2.6

0.70

0.86

g/l

1.11

1553

5209

(3028626) Oxygen [Partial pressure] in Capillary blood

1366

4087

1.85

85.73

3.2

3.3

8.35

8.33

kpa

0.21

1334

3986

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1247

3666

1.88

82.55

2.0

1.7

—

(3017181) Myelocytes/Leukocytes in Blood

4143

16389

1.42

82.45

4.0

4.6

0.87

0.98

1.50

1179

5122

(3021440) Promyelocytes/Leukocytes in Blood

3992

15701

1.43

81.98

4.1

4.6

0.10

0.12

0.85

1037

4466

(3052851) Hemolysis interference index of Serum or Plasma

1446

4499

1.78

80.02

3.3

3.2

1.93

2.37

index

1.47

743

2258

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

666

1549

2.37

79.96

1.3

1.2

36.70

30.14

nmol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

680

1601

2.34

79.50

1.6

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

848

2206

2.12

78.50

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

2399

8576

1.56

78.37

2.2

2.1

0.35

0.14

estimate

0.28

766

2787

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1940

6610

1.63

77.30

2.3

2.5

2.86

2.90

g/l

0.87

1740

6098

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2318

8251

1.56

77.11

4.4

3.9

49.32

46.53

5.63

2287

8140

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1613

5241

1.71

76.83

1.3

31.44

45.20

u/ml

0.95

296

(3016038) Potassium [Moles/volume] in Urine

437

841

2.86

75.65

1.3

1.2

32.50

36.57

mmol/l

2.76

370

761

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1673

5523

1.68

75.18

1.7

1.21

1.18

g/l

4.14

1603

5302

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1625

5369

1.68

72.77

1.8

1.7

0.24

g/l

0.36

1554

5130

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2021

7065

1.59

72.49

2.3

2.5

7.35

7.36

g/l

0.04

1822

6553

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2018

7059

1.59

72.19

2.3

2.5

4.23

4.20

g/l

0.80

1819

6551

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5130

21461

1.35

72.14

5.2

4.7

31.25

32.40

10.43

3541

14597

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2012

7050

1.59

71.45

2.3

2.5

3.72

3.73

g/l

0.07

1817

6540

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1284

3988

1.78

71.41

2.4

2.2

132.12

130.59

g/l

1.19

961

3031

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1504

4893

1.70

71.26

2.4

2.5

0.00

g/l

0.11

1294

4342

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2180

7789

1.56

71.21

1.9

2.1

40.05

39.54

u/l

0.50

1934

6973

(3021901) Oxygen saturation in Capillary blood

1114

3334

1.85

69.78

3.1

90.34

90.24

0.19

1083

3243

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1552

5127

1.68

69.51

2.4

0.02

g/l

0.04

1383

4666

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

572

1333

2.36

68.43

1.7

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2238

8147

1.53

67.16

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1213

3773

1.78

67.12

1.3

35.35

49.36

u/ml

1.73

104

356

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1353

4350

1.72

66.84

1.1

4.16

6.96

eliau/ml

1.68

162

573

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1379

4485

1.70

65.36

1.2

4.34

3.82

0.60

166

700

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

723

1902

2.09

65.10

2.2

1.9

5058.18

3189.52

titre

0.46

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

568

1359

2.30

64.15

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

64.03

1.4

0.0

570.85

—

nmol/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1743

6068

1.59

63.47

2.3

2.4

9.92

10.33

g/l

3.44

1526

5499

(3048929) Epstein Barr virus Ab [Presence] in Serum

1767

6191

1.58

62.64

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1122

3487

1.78

62.25

1.7

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1755

6151

1.58

62.12

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

1283

4150

1.71

62.01

3.4

3.5

61.30

63.02

1.79

1226

4054

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3605

14605

1.38

61.45

2.7

68.70

65.85

ml/min/173m2

3.56

1563

5938

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1386

4598

1.67

61.04

2.5

0.00

g/l

-0.00

1290

4336

(3022806) Fractional oxyhemoglobin in Capillary blood

663

1734

2.10

60.61

1.9

1.7

89.56

90.12

1.52

650

1703

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1474

4984

1.64

60.34

1.3

7.33

8.54

u/ml

0.27

197

748

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2207

8195

1.50

60.20

1.7

1.8

1.53

1.52

g/l

0.24

1890

7078

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3622

14741

1.37

59.97

2.6

2.5

0.39

0.36

e6/l

0.33

3468

14083

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1473

4993

1.63

59.71

1.3

4.76

6.97

u/ml

0.47

115

500

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

836

2408

1.91

58.79

1.5

0.34

0.42

nmol/l

1.49

624

1892

(4024509) Urine culture

2054

7556

1.51

58.54

2.0

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3278

13181

1.39

58.31

3.0

2.9

165.78

211.39

ng/l

6.58

2968

12095

(3016244) Insulin [Units/volume] in Serum or Plasma

416

902

2.53

57.87

3.2

3.0

32.26

22.84

mu/l

3.75

389

850

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2120

7877

1.49

57.60

1.5

1.7

10.58

15.76

iu/ml

0.75

263

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

31736

164294

1.21

57.09

23.8

16.7

332.86

332.77

g/l

0.90

31568

163325

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

810

2336

1.91

56.77

1.3

1.4

0.13

0.25

nmol/l

1.96

144

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

799

2301

1.91

56.23

1.3

1.4

0.62

1.73

nmol/l

0.99

771

2228

(3022621) pH of Urine by Test strip

3482

14259

1.36

55.25

2.6

2.4

6.07

6.05

0.50

2274

9528

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1882

6880

1.52

55.19

2.0

1.9

1.99

2.49

ug/l

0.88

1650

6225

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1381

4699

1.62

55.12

2.0

11.11

12.90

iu/l

0.09

544

1943

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1831

6697

1.51

53.54

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1802

6570

1.52

53.48

1.8

1.7

4.13

4.29

mg/l

0.23

1460

4500

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

483

1169

2.27

53.24

1.2

1.1

38.54

51.23

mg/l

4.14

413

1009

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

376

819

2.52

51.89

1.1

2.99

8.38

nmol/l

1.51

166

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2616

10319

1.41

51.83

10.5

16.16

16.13

0.20

2539

9937

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1630

5868

1.54

51.24

2.0

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1259

4268

1.63

50.98

1.2

1.3

1.69

6.23

u/ml

2.62

318

(3016650) Hepatitis A virus Ab [Presence] in Serum

928

2894

1.77

50.91

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

465

1130

2.26

50.81

1.1

258.87

290.43

mg/l

1.38

409

1017

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1761

6460

1.51

50.76

2.2

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

826

2490

1.83

50.61

1.1

1.50

g/l

0.06

755

2290

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

707

2026

1.92

50.52

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1313

4523

1.60

49.85

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

967

3073

1.73

49.75

1.5

1.7

0.73

0.85

g/l

2.39

747

2398

(4027681) Cerebrospinal fluid IgG ratio and IgG index

379

851

2.44

49.20

1.2

0.63

0.66

ratio

0.35

225

492

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

714

2073

1.90

49.10

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1338

4652

1.59

48.89

1.2

1.3

—

(3003129) Base excess in Capillary blood by calculation

675

1926

1.93

48.85

2.1

2.2

0.61

0.23

mmol/l

1.69

659

1848

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

638

1787

1.96

48.68

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

440

1064

2.27

48.64

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

441

1069

2.26

48.49

1.3

1.2

1.99

2.18

mmol/l

2.28

407

997

(3024522) Salmonella sp identified in Specimen by Organism specific culture

701

2034

1.90

48.30

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1298

4496

1.59

48.18

1.2

1.3

0.58

15.46

u/ml

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

691

2000

1.90

47.97

1.3

0.19

0.32

nmol/l

0.60

525

1615

(3027273) Bicarbonate [Moles/volume] in Venous blood

2005

7651

1.45

47.49

3.9

3.5

25.34

25.23

mmol/l

0.65

1935

7419

(3040151) Glucose [Moles/volume] in Capillary blood

619

1732

1.96

47.37

6.5

5.8

7.39

7.17

mmol/l

0.69

521

1406

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1409

4997

1.56

47.31

1.9

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

701

2065

1.87

46.18

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

648

1861

1.91

46.04

2.0

25.43

27.21

mg/l

0.35

230

731

(3005988) Vibrio sp identified in Specimen by Organism specific culture

667

1936

1.89

45.94

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

665

1935

1.89

45.47

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

661

1929

1.88

44.80

1.4

—

(3037121) Protein [Mass/volume] in Urine

1617

5987

1.49

44.54

3.2

3.6

468.47

502.23

mg/l

0.10

725

2974

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

381

900

2.32

44.44

1.4

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

309

661

2.56

44.28

1.9

1.8

1.93

1.99

umol/l

0.48

285

605

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

267

530

2.76

44.01

2.5

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1601

5946

1.49

43.44

3.1

3.7

36.62

49.02

mg/l

2.66

1327

5128

(3014271) Vancomycin [Susceptibility]

268

538

2.73

43.30

3.2

2.7

—

(3011985) Renin [Units/volume] in Plasma

790

2467

1.76

43.19

1.6

80.80

56.76

mu/l

1.42

701

2246

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

910

2968

1.69

42.70

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

287

603

2.61

42.60

1.2

1.3

65.83

66.72

0.04

(3034860) Kappa light chains.free [Mass/volume] in Serum

1599

5962

1.48

42.55

3.1

3.7

51.31

67.13

mg/l

0.93

1326

5135

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

568

1618

1.93

41.38

1.2

1.3

—

titre

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

738

2294

1.77

41.00

1.3

1.4

309.18

348.62

pmol/l

0.38

631

1981

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

471

1260

2.05

40.79

1.1

284.13

289.83

mg/l

0.75

428

1169

(3020717) Zinc [Moles/volume] in Serum or Plasma

343

810

2.32

40.09

1.6

1.5

17.41

25.44

umol/l

6.02

313

751

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1139

3999

1.57

39.94

1.1

2.17

2.43

u/ml

0.33

621

2170

(40768443) Skin Pathology biopsy report

2104

8354

1.39

39.91

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1280

4623

1.53

39.61

1.6

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

203

367

3.03

39.30

1.2

1.3

19.70

20.79

0.06

(3017315) Amylase [Enzymatic activity/volume] in Urine

328

768

2.34

39.08

1.4

1.2

285.25

394.82

u/l

0.81

303

715

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

217

411

2.89

38.89

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

1049

3640

1.59

38.67

3.3

3.1

61.46

63.86

2.70

1043

3628

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

206

380

2.97

38.60

3.1

3.0

27.81

28.68

umol/l

0.46

153

305

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

256

535

2.62

38.45

2.6

2.4

54.96

49.48

umol/l

1.79

219

474

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

403

1040

2.13

38.29

1.2

1.3

—

(3045716) Anion gap in Serum or Plasma by calculation

557

1626

1.88

37.80

2.9

3.1

10.71

10.74

mmol/l

0.04

551

1604

(3024139) IgG subclass 3 [Mass/volume] in Serum

614

1852

1.82

37.66

1.4

0.39

0.43

g/l

1.16

436

1335

(3028192) IgG subclass 2 [Mass/volume] in Serum

614

1852

1.82

37.66

1.4

2.91

3.07

g/l

1.21

433

1339

(3027135) IgG subclass 1 [Mass/volume] in Serum

614

1855

1.82

37.47

1.4

6.48

6.96

g/l

2.58

435

1339

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

318

749

2.33

37.43

1.1

—

(4062490) Immunoglobulin typing, IgG

606

1825

1.82

37.36

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

396

1030

2.11

36.92

1.2

1.3

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

335

813

2.26

36.88

1.4

1.3

5.09

5.20

umol/l

0.16

288

730

(3029634) Reagin Ab [Titer] in Serum by VDRL

772

2508

1.69

36.80

2.7

2.2

10.29

6.10

titre

0.39

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1234

4505

1.51

36.34

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

292

672

2.38

36.16

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

341

842

2.22

36.08

1.1

1.05

1.17

u/l

1.33

133

360

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1408

5296

1.47

35.85

3.1

3.6

3.80

6.96

ratio

0.67

780

3060

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

292

675

2.37

35.82

1.7

1.3

1865396.52

3134763.60

iu/ml

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1124

4034

1.54

35.81

1.5

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

351

885

2.17

35.35

1.5

5.74

6.24

u/l

0.45

303

754

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1541

5915

1.44

35.30

1.4

1.3

224.87

223.44

miu/ml

0.05

628

2865

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1400

5281

1.46

35.13

1.5

13.96

13.60

iu/ml

0.03

124

(3000475) Leukocytes [#/volume] in Synovial fluid

1237

4553

1.50

35.05

1.6

1.7

14648.92

13424.09

e6/l

0.30

863

3313

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

228

472

2.65

34.92

2.3

2.8

0.87

1.06

ug/l

0.71

218

454

(3003888) Timothy IgE Ab [Units/volume] in Serum

989

3468

1.57

34.90

1.1

5.22

5.29

u/ml

0.05

542

1867

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

766

2526

1.67

34.58

1.2

18.36

17.71

u/ml

0.03

102

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

954

3327

1.58

34.46

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1355

5098

1.47

34.45

2.0

2.2

11.16

11.57

mg/l

1.03

1266

4798

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

277

640

2.37

34.05

1.8

1.7

27.76

29.12

umol/l

1.22

259

604

(3008401) Mugwort IgE Ab [Units/volume] in Serum

950

3326

1.57

33.76

1.1

1.12

1.08

u/ml

0.06

433

1506

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1590

6205

1.41

33.26

2.7

2.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

213

437

2.67

33.21

1.4

14.22

15.85

pmol/l

2.15

172

378

(3036489) Thrombin time

1753

6963

1.39

33.12

2.1

2.2

21.13

21.18

0.10

1548

6181

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1027

3677

1.54

33.10

2.3

2.0

0.89

0.84

nmol/l

1.28

843

3154

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1055

3804

1.53

32.93

1.3

268.98

255.35

u/ml

0.76

659

2428

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1117

4082

1.51

32.76

1.3

63.61

42.30

u/ml

0.30

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

957

3384

1.56

32.59

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

283

674

2.30

32.58

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

956

3380

1.56

32.58

1.2

1.3

148.89

148.00

titre

0.00

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

946

3357

1.55

31.73

1.2

1.3

310.08

301.20

titre

0.04

254

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

860

2985

1.58

31.72

1.1

18.46

14.49

au/ml

0.80

192

881

(3006270) Folate [Moles/volume] in Blood

384

1048

2.01

31.67

1.2

1.1

373.08

354.64

nmol/l

0.87

330

877

(40757494) Bilirubin.total [Moles/volume] in Blood

285

696

2.24

31.03

2.3

2.2

18.22

35.75

umol/l

0.95

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

186

371

2.74

30.58

1.3

1.2

125.42

127.73

nmol/l

0.05

126

275

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.89

30.21

2.1

2.6

16.80

21.78

umol/l

1.68

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

290

724

2.19

30.00

2.0

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

539

1678

1.76

29.93

1.4

1.3

1.39

1.40

nmol/l

0.09

486

1523

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

6.10

29.84

1.2

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

710

2390

1.63

29.68

6.9

6.2

11.83

11.67

mg/l

0.38

659

2227

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

141

243

3.17

29.59

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

669

2225

1.65

29.31

1.3

68.07

56.90

u/ml

0.42

127

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

867

3073

1.55

29.26

1.6

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

910

3263

1.53

29.17

1.1

1.93

1.70

u/ml

0.35

502

1624

(3007463) Buprenorphine [Presence] in Urine

+∞

29.17

5.6

0.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

283

709

2.19

29.06

1.6

4.56

7.92

nmol/l

0.43

211

609

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

358

985

1.99

28.93

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3821

25113

0.81

28.91

1.9

3.59

3.51

ratio

3.01

2887

19314

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1908

7855

1.34

28.77

5.4

4.8

1.75

1.57

7.94

1816

7436

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1362

5308

1.41

28.72

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

149

272

3.00

28.56

1.9

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

332

895

2.03

28.36

1.6

1.5

1.20

1.23

nmol/l

0.13

240

703

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

442

1317

1.84

28.32

1.1

1.3

109.51

110.93

pmol/l

0.21

442

1317

(3020911) Cortisol [Moles/time] in 24 hour Urine

219

497

2.41

28.07

1.4

1.5

233.27

287.09

nmol/24h

0.14

219

497

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

824

2916

1.55

28.02

1.5

1.6

19.80

13.67

u/ml

0.45

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

346

953

1.99

27.90

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

242

577

2.30

27.88

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

796

2798

1.56

27.88

1.3

—

20.00

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

767

2675

1.58

27.78

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1274

4945

1.42

27.48

1.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1464

5826

1.38

27.35

3.6

1.52

mg/l

0.09

1339

5385

(3010838) Calcium [Moles/time] in 24 hour Urine

865

3115

1.53

27.22

1.8

2.0

5.09

5.20

mmol/24h

0.40

774

2808

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

720

2486

1.59

27.21

1.1

2.13

3.02

1.73

107

428

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1074

4051

1.46

27.01

1.5

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1576

6363

1.37

26.95

1.6

1.5

11.52

6.71

iu/ml

0.17

265

1179

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

240

582

2.26

26.64

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

651

2209

1.62

26.43

1.5

1.6

—

(3001186) Copper [Moles/volume] in Serum or Plasma

181

387

2.56

26.21

1.3

1.2

16.26

16.32

umol/l

0.05

157

341

(3004616) Nuclear Ab [Presence] in Serum

652

2219

1.61

26.16

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

261

662

2.16

26.08

1.1

6.39

10.28

u/ml

1.23

121

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

336

939

1.96

26.07

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

1285

5047

1.40

25.94

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

450

1389

1.78

25.79

1.1

—

(3023419) Bacteria identified in Sputum by Culture

642

2185

1.61

25.76

2.7

2.5

—

(4146454) Self-monitoring of blood glucose

554

1826

1.66

25.20

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

422

1287

1.80

25.18

1.3

1.67

2.30

u/ml

0.63

238

750

(21494755) Public health laboratory ask at order entry panel

3273

21556

0.81

25.04

1.3

1.4

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

5.87

25.03

1.2

1.1

47.83

38.25

mg/l

1.21

(3042631) Mycobacterium sp identified in Specimen

657

2266

1.59

24.99

2.8

2.5

—

(44813793) Dust mix specific IgE antibody measurement

394

1181

1.83

24.85

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

739

2629

1.54

24.62

1.2

—

(3047181) Lactate [Moles/volume] in Blood

1276

5053

1.39

24.57

6.2

5.8

1.35

1.29

mmol/l

1.27

1115

4464

(4034850) Laboratory test

1291

5124

1.39

24.52

11.5

9.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

1038

3970

1.44

24.30

3.1

3.8

—

0.86

—

(3002256) Pathology report gross observation

5480

25896

1.18

24.17

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

280

757

2.03

23.84

1.3

1.2

159.81

161.61

mmol/24h

0.11

280

757

(3037756) Immunofixation for Serum or Plasma

953

3603

1.45

23.72

1.5

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1121

8396

0.72

23.48

1.1

0.65

0.63

ratio

0.55

134

1009

(3019420) Tryptase [Mass/volume] in Serum or Plasma

336

977

1.88

23.30

1.5

1.6

8.14

8.33

ug/l

0.07

308

898

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

548

1841

1.63

23.21

1.2

61.46

64.47

u/l

0.32

480

1635

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

360

1074

1.84

23.09

1.2

1.1

1.07

3.78

0.48

(3038177) Helicobacter pylori Ab [Presence] in Serum

787

2880

1.50

23.05

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

382

1162

1.80

23.04

1.1

—

0.54

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

14.90

22.80

1.1

1.0

—

mmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

341

1012

1.85

22.25

1.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

2837

18724

0.81

22.02

1.6

3.48

3.49

mmol/l

0.18

1936

12714

(3008116) Ketones [Moles/volume] in Urine by Test strip

135

272

2.71

21.96

1.7

1.3

0.20

0.28

mmol/l

0.41

(3014133) Dog dander IgE Ab [Units/volume] in Serum

776

2863

1.49

21.88

1.1

5.50

3.39

u/ml

1.29

391

1434

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

198

483

2.24

21.80

1.5

72.29

71.82

0.16

190

469

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

805

2998

1.47

21.67

1.1

1198.34

770.42

iu/ml

0.14

182

579

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

185

440

2.30

21.57

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

435

1403

1.70

21.52

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

128

255

2.75

21.27

1.1

0.72

5.87

umol/24h

0.49

137

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

255

696

2.01

21.23

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

255

696

2.01

21.23

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

735

2699

1.50

21.22

1.1

6.75

4.30

u/ml

1.54

346

1219

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

194

475

2.24

21.19

1.5

365.29

981.11

mu/l

1.75

186

461

(3035320) C reactive protein [Mass/volume] in Body fluid

405

1287

1.72

21.13

3.2

2.1

25.71

30.32

mg/l

1.40

287

912

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

497

1671

1.63

21.04

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

487

1634

1.63

20.79

3.9

—

(3032057) Clostridioides difficile [Presence] in Stool

122

240

2.78

20.75

1.8

1.7

—

(3004451) EKG impression Narrative

309

912

1.86

20.56

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

387

1224

1.73

20.55

2.7

2.5

0.74

0.65

e9/l

1.19

369

1177

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

379

1192

1.74

20.52

1.3

1.4

12.30

12.73

umol/l

0.50

358

1144

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

402

1287

1.71

20.45

1.4

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1427

5925

1.33

20.34

2.7

3.61

3.59

g/l

0.19

1363

5713

(3041806) Other cells [#/volume] in Blood by Manual count

196

491

2.18

20.32

1.5

1.3

0.49

0.54

e9/l

1.83

196

491

(3011048) Pyruvate [Moles/volume] in Blood

5.17

20.01

1.4

1.2

88.59

68.86

umol/l

1.94

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

668

2435

1.51

20.00

1.1

2.38

3.25

eliau/ml

1.46

282

1183

(3007930) Methemoglobin/Hemoglobin.total in Blood

1691

7207

1.29

19.93

5.8

5.0

0.88

0.04

1604

6805

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

522

1802

1.59

19.90

1.6

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

393

1262

1.71

19.80

1.1

7.37

8.55

iu/ml

0.38

348

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1444

6035

1.32

19.66

2.3

2.4

92.97

92.09

0.72

1391

5834

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

19.45

1.3

0.0

145.11

—

nmol/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

633

2298

1.51

19.34

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1339

5551

1.33

19.31

2.6

2.7

191.31

193.71

0.39

1272

5297

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1441

6041

1.31

19.20

3.6

3.2

0.35

0.34

iu/ml

0.53

779

3257

(43055514) Macroprolactin [Presence] in Serum or Plasma

154

358

2.35

18.95

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

100

185

2.96

18.93

1.8

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

443

1489

1.63

18.84

1.1

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

451

1525

1.62

18.74

1.1

1.2

—

(3036180) Methadone [Presence] in Urine

+∞

18.64

2.6

0.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

330

1029

1.76

18.46

2.6

2.2

98.71

96.66

0.41

308

973

(3017569) Oxygen content in Arterial blood

285

850

1.84

18.42

2.4

2.0

16.27

15.95

0.79

285

850

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1027

4122

1.37

18.32

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

363

1170

1.70

18.10

1.4

1.6

26.05

24.02

u/ml

0.26

196

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1021

4108

1.37

17.95

2.4

2.5

142.46

99.79

ug/min

1.48

608

2517

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

576

2084

1.52

17.92

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

165

3.01

17.83

1.9

2.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

433

1469

1.62

17.78

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1292

9104

0.77

17.72

1.2

0.90

0.89

g/l

1.24

1287

9078

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

433

1471

1.61

17.69

1.2

—

(3000012) Reticulocyte production index

659

2463

1.47

17.53

2.2

2.3

0.93

0.91

0.34

435

1700

(3013247) Albumin in CSF/Albumin in Serum or Plasma

141

329

2.34

17.27

1.1

6.39

7.24

mg/g

0.78

134

314

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

420

1425

1.61

17.26

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

166

2.96

17.17

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4134

19604

1.17

17.10

3.7

4.7

18.65

30.09

ug/l

1.67

3342

15890

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1010

4092

1.36

17.01

1.4

1.5

20.92

23.14

u/ml

0.14

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

426

1457

1.60

16.96

1.4

1.3

187.95

183.04

pmol/l

0.08

426

1457

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

368

1213

1.66

16.93

2.7

2.5

519.19

545.41

e6/l

0.29

295

986

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

319

1012

1.73

16.87

1.3

506.50

552.13

titre

0.06

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

811

3174

1.40

16.86

1.2

1.3

28.87

34.16

u/l

0.46

698

2789

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

432

1485

1.59

16.85

1.2

162.00

211.54

titre

0.21

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

416

1417

1.61

16.84

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

433

1490

1.59

16.82

1.2

140.00

220.73

titre

1.28

246

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

645

2421

1.46

16.81

1.1

0.49

0.34

u/ml

0.45

207

724

(3010144) Erythrocytes [#/volume] in Synovial fluid

476

1677

1.56

16.73

1.3

1.4

138697.85

105968.80

e6/l

0.42

313

1090

(3018333) Ribosomal P Ab [Presence] in Serum

406

1377

1.62

16.73

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

476

1681

1.55

16.56

3.7

3.5

13.89

13.17

index

0.52

284

938

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

149

364

2.24

16.49

1.6

0.38

0.39

ug/l

0.10

102

263

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

692

2643

1.44

16.48

2.8

3.1

200.18

765.68

u/ml

1.19

682

2613

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

311

987

1.73

16.44

1.3

66.67

88.46

titre

0.40

(3028717) Thiamine [Mass/volume] in Blood

153

3.00

16.38

1.2

60.54

62.72

ug/l

0.37

153

(3012565) Volume of 24 hour Urine

274

839

1.79

16.35

2.1

2.2

2008.04

1971.52

0.18

252

762

(4015189) Microbial culture of sputum

152

376

2.21

16.35

2.4

2.0

—

(3024869) Neuronal Ab [Presence] in Serum

114

247

2.52

16.30

1.1

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

+∞

16.20

1.2

0.0

139.55

—

nmol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

128

296

2.36

16.02

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

473

1684

1.54

15.90

1.6

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

391

3300

0.64

15.78

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

191

526

1.99

15.68

1.9

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

558

2065

1.48

15.66

1.1

0.82

2.18

iu/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

526

1926

1.50

15.55

1.2

58.32

46.47

u/ml

0.33

105

(44806118) Parainfluenza type 4 nucleic acid detection

611

2306

1.45

15.53

1.5

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

611

2306

1.45

15.53

1.5

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

611

2306

1.45

15.53

1.5

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

611

2308

1.45

15.46

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

578

2162

1.47

15.39

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

451

1605

1.54

15.22

1.2

70.43

69.89

u/ml

0.01

(3044242) Glucose [Moles/volume] in Arterial blood

266

829

1.76

15.02

2.2

1.8

7.78

8.14

mmol/l

0.90

266

829

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

423

1490

1.56

14.95

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

423

1490

1.56

14.95

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

423

1490

1.56

14.95

1.6

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

138

341

2.21

14.93

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

361

1228

1.61

14.77

3.3

3.9

115.67

171.54

nmol/l

1.53

356

1215

(3044927) Protein electrophoresis panel - Urine

444

1586

1.53

14.75

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

140

350

2.19

14.74

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

780

3106

1.38

14.70

3.3

3.1

0.80

0.82

nmol/l

0.43

610

2498

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

208

2.58

14.64

1.1

1.0

88.87

83.07

ug/l

0.58

153

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

+∞

14.58

5.5

0.0

1206.00

—

nmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

165

443

2.04

14.55

1.1

—

(3011412) CD3 cells [#/volume] in Blood

484

1769

1.50

14.47

2.7

2.3

1267.55

1168.59

e6/l

0.79

420

1571

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

433

1547

1.53

14.39

4.7

6.2

61.99

116.70

u/ml

1.51

134

595

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

919

3772

1.34

14.29

1.5

144.02

149.86

au/ml

0.67

252

1124

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

321

1071

1.64

14.20

1.3

99.64

95.30

u/l

0.22

277

926

(3025130) Human papilloma virus identified in Specimen

666

2602

1.40

14.07

1.7

1.8

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

310

1029

1.65

14.00

1.6

7.14

6.85

u/l

0.11

240

842

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

123

3.07

14.00

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

312

1038

1.65

13.97

1.3

25.80

28.32

u/l

0.30

261

885

(3028679) Herpes simplex virus Ab [Presence] in Serum

294

964

1.67

13.91

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

101

225

2.45

13.74

1.5

1.4

0.30

0.21

nmol/l

0.69

164

(3038026) Centromere Ab [Units/volume] in Serum

387

1363

1.55

13.73

1.2

61.46

53.78

u/ml

0.16

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1037

4359

1.31

13.67

5.5

6.2

6214.74

1193.51

iu/ml

0.49

124

700

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

125

3.02

13.65

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

817

3319

1.35

13.62

2.7

2.9

428.95

7442.84

u/ml

1.49

196

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

435

1578

1.51

13.52

2.9

2.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

601

2331

1.41

13.27

2.1

2.3

7.89

7.33

umol/l

0.18

428

1718

(3017509) Phencyclidine [Presence] in Urine

116

3.06

13.19

1.5

1.0

—

(21494815) CD4 cells/Lymphocytes in Specimen

452

1663

1.49

13.15

2.5

2.1

39.73

37.20

2.91

445

1633

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2011

9164

1.21

13.14

3.0

3.8

70.32

57.76

u/ml

0.35

1933

8903

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

362

1269

1.56

13.13

2.8

2.6

229.17

234.03

e6/l

0.18

306

1085

(3051651) Icteric interference index of Serum or Plasma

291

968

1.65

13.07

4.0

0.88

0.90

index

0.11

282

938

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

201

601

1.83

13.07

1.3

0.30

0.31

g/l

0.93

162

488

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

302

1017

1.63

12.94

1.9

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

162

452

1.96

12.93

1.1

2.73

11.71

u/ml

0.67

265

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

184

537

1.87

12.89

1.2

108.11

103.66

0.68

167

493

(3028433) Virus identified in Specimen by Culture

177

512

1.89

12.74

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

211

648

1.78

12.61

1.0

1.1

850.52

457.99

ng/l

0.34

199

(3002619) Bacteria identified in Specimen by Culture

151

415

1.99

12.58

1.4

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

293

988

1.62

12.51

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

245

788

1.70

12.50

4.1

3.8

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

443

1641

1.48

12.49

1.4

1.6

28.95

31.89

0.89

271

1058

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

552

2134

1.42

12.44

3.3

3.6

5.22

11.38

nmol/l

0.98

532

2071

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

177

517

1.87

12.40

1.2

90.46

86.20

0.60

262

(37208534) Antinuclear antibody arbitrary concentration in serum

190

568

1.83

12.39

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1632

10753

0.82

12.36

1.5

1.6

1020.98

1025.26

mu/l

0.05

1348

9283

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

282

945

1.63

12.35

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

283

952

1.63

12.21

1.1

1629.27

1479.32

miu/ml

1.32

283

952

(3010015) Selenium [Moles/volume] in Serum or Plasma

116

2.97

12.19

2.1

1.7

1.34

1.35

umol/l

0.07

(3010370) Gastrin [Moles/volume] in Serum or Plasma

105

254

2.26

12.04

2.0

1.7

44.35

51.51

pmol/l

0.30

213

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

185

554

1.83

12.02

1.2

1.3

108.73

111.64

0.70

167

502

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.24

12.00

1.6

1.8

47.69

53.62

umol/l

0.65

(3014148) Varicella zoster virus Ab [Titer] in Serum

674

2713

1.36

11.99

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

674

2713

1.36

11.99

1.1

119.02

116.08

1.41

620

2485

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

177

526

1.84

11.79

1.1

90.81

87.02

0.78

263

(4195642) Thrombophilia screening test

670

2705

1.36

11.70

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1033

7098

0.79

11.63

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.17

11.63

1.7

1.3

5.74

16.47

pmol/l

1.06

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

226

728

1.70

11.51

1.1

1.2

27.26

16.16

u/ml

0.29

(3020491) Glucose [Moles/volume] in Blood

340

1213

1.53

11.49

1.7

6.85

6.57

mmol/l

0.90

251

859

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

196

608

1.76

11.39

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

112

2.93

11.38

1.7

1.6

2.55

1.79

mg/l

0.41

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

696

2847

1.34

11.19

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

100

3.00

10.90

1.3

25.47

13.69

nmol/l

0.52

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

377

1.96

10.84

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

124

337

2.01

10.73

1.2

277.09

272.97

pmol/l

0.04

259

(3001556) Androgen free Index in Serum or Plasma

129

2.71

10.66

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

307

1090

1.54

10.65

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1047

4558

1.26

10.58

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

564

2254

1.37

10.56

1.5

1.6

61.35

56.52

2.02

354

1490

(3039000) Anion gap in Blood by calculation

828

3502

1.30

10.54

7.8

6.9

11.48

11.20

mmol/l

1.46

747

3140

(3018572) Chloride [Moles/volume] in Blood

828

3503

1.30

10.52

7.8

6.9

104.62

105.31

mmol/l

3.84

747

3143

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

709

2936

1.32

10.52

1.2

3.90

3.83

u/ml

0.05

328

1440

(1175426) CD3 cells/Lymphocytes in Blood

385

1438

1.47

10.51

2.4

2.0

73.88

71.79

2.01

366

1393

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

120

326

2.01

10.41

1.2

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

2.33

2.41

mg/l

0.03

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

2.21

1.40

mg/l

0.94

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

1.75

1.88

mg/l

0.05

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

1.53

3.22

mg/l

1.39

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

1.42

1.14

mg/l

0.17

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

1.19

0.65

mg/l

0.61

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

3.06

1.70

mg/l

0.86

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

2.18

1.37

mg/l

0.52

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

108

2.83

10.10

1.7

1.5

3.71

3.98

mg/l

0.08

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

207

677

1.67

10.05

2.4

2.0

28.32

30.18

1.14

200

644

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

368

1379

1.46

9.91

2.3

2.0

14.14

15.88

2.70

361

1347

(3000330) Specific gravity of Urine by Test strip

1949

9088

1.18

9.91

3.5

3.2

1.02

ratio

3.53

1734

8241

(3020874) Milk IgE Ab [Units/volume] in Serum

320

1166

1.50

9.90

1.1

1.43

1.74

u/ml

0.15

126

368

(3008757) Leukocyte morphology finding [Identifier] in Blood

461

1802

1.40

9.88

3.2

4.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

293

1048

1.53

9.87

2.0

106.06

107.20

ng/l

0.06

293

1043

(3014599) Egg white IgE Ab [Units/volume] in Serum

313

1136

1.51

9.86

1.1

2.64

2.84

u/ml

0.04

285

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

144

2.50

9.51

2.7

3.9

42.21

41.30

umol/l

0.11

116

(40761539) Cells [Type] in Urine sediment by Light microscopy

125

357

1.91

9.49

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

360

1357

1.45

9.44

2.4

2.0

—

(3006245) CD3-CD19+ cells/cells in Blood

209

699

1.64

9.36

2.6

2.2

9.30

10.62

0.75

201

646

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

275

983

1.53

9.33

1.2

81.35

83.39

u/l

0.16

241

891

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

926

4040

1.26

9.25

1.6

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

117

2.66

9.24

1.3

1.2

0.68

0.60

iu/ml

0.11

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

719

3041

1.30

9.22

1.2

1.3

3.74

3.51

u/ml

0.13

266

1219

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

232

800

1.59

9.20

1.7

140.71

153.49

1.62

216

755

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.37

9.20

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

109

300

1.99

9.19

1.3

61.19

67.85

mu/l

0.17

228

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

140

2.50

9.19

1.2

1.60

1.70

iu/ml

0.17

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.53

9.18

1.4

1.1

1.98

2.41

g/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

565

2313

1.34

9.14

2.4

2.6

1.34

1.28

g/24h

0.17

315

1487

(3003694) ABO and Rh group [Type] in Blood

11468

59306

1.08

9.09

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

272

976

1.52

9.08

1.2

21.17

23.45

u/l

0.32

240

882

(21491868) Cryoglobulin [Mass/volume] in Serum

187

613

1.67

9.06

1.2

0.63

0.36

g/l

0.22

(3020650) Glucose [Presence] in Urine

191

635

1.64

8.79

1.7

1.4

0.05

0.06

estimate

0.18

191

635

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

200

673

1.63

8.78

2.9

2.8

0.61

mmol/l

0.08

200

673

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

198

665

1.63

8.76

2.0

2.2

40.35

40.65

g/l

0.28

198

665

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1316

5999

1.20

8.69

1.5

1.4

—

(3051339) Copper [Moles/volume] in Blood

3.31

8.59

1.1

1.2

16.67

16.16

umol/l

0.21

(3000060) B lymphocytes [#/volume] in Blood

161

515

1.71

8.56

2.5

2.0

1.03

0.59

e9/l

0.21

229

(3002523) Influenza virus A Ag [Presence] in Specimen

822

3575

1.26

8.48

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

238

843

1.54

8.46

1.2

1.1

3.17

3.71

iu/ml

0.55

(3024263) Appearance of Synovial fluid

244

871

1.53

8.38

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

819

3572

1.26

8.26

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

217

757

1.57

8.26

2.5

2.8

23.24

371.10

ug/l

1.71

205

728

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

228

805

1.55

8.24

2.2

2.1

100.26

68.09

ug/min

0.39

184

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

131

400

1.79

8.17

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

142

2.39

8.16

1.0

1.1

0.54

2.47

u/ml

0.69

119

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

140

437

1.75

8.12

1.2

1.1

15.56

12.26

pmol/l

0.37

173

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

129

2.46

8.11

1.0

1.1

0.03

0.04

u/ml

0.08

129

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

129

2.46

8.11

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

101

284

1.94

8.09

1.1

2.25

4.62

u/ml

0.77

195

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

262

960

1.49

8.00

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

240

2.03

7.99

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.90

7.98

1.9

1.8

206.30

173.57

ug/g

0.53

(40768800) Prostate Pathology biopsy report

645

4471

0.78

7.97

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

436

1756

1.36

7.92

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

141

2.36

7.89

1.0

0.03

0.33

u/ml

1.57

(3033799) Differential panel - Peritoneal fluid

164

541

1.66

7.83

2.1

1.8

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

177

596

1.62

7.81

1.7

1.8

165.36

178.46

0.78

165

568

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

213

2.08

7.78

1.6

1.7

5.16

7.65

nmol/l

0.71

207

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

218

2.06

7.66

2.3

2.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

283

1063

1.46

7.66

1.1

1.2

1.05

1.07

ratio

2.11

233

889

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

350

1368

1.40

7.64

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

105

306

1.88

7.61

3.1

2.9

55.38

54.42

mg/l

0.02

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

147

475

1.69

7.59

3.5

2.6

5.05

4.95

kpa

0.43

147

475

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

147

475

1.69

7.59

3.5

2.6

10.14

10.45

kpa

0.63

147

475

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

837

5603

0.81

7.58

1.4

1.5

1.15

1.19

ratio

0.63

491

3479

(3002331) Protein [Mass/volume] in Peritoneal fluid

127

394

1.76

7.56

1.4

1.3

22.36

42.04

g/l

0.77

318

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

839

5613

0.81

7.55

1.4

1.5

1.24

1.18

ratio

0.92

496

3525

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

839

5613

0.81

7.55

1.4

1.5

0.95

0.94

ratio

0.17

494

3487

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

895

5948

0.82

7.54

1.5

1.6

60.12

63.15

ug/l

1.16

732

5032

(40768793) Breast Pathology biopsy report

907

4045

1.23

7.52

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

297

1133

1.43

7.43

2.9

2.7

40.20

37.45

1.57

153

613

(3011841) English Walnut IgE Ab [Units/volume] in Serum

142

2.31

7.40

1.0

1.1

2.33

3.61

u/ml

0.22

121

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

190

661

1.57

7.37

2.6

2.8

155.47

139.14

au/ml

0.15

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

178

2.15

7.33

1.3

43.72

60.91

1.71

(3013166) Neutrophils/Leukocytes in Synovial fluid

145

472

1.68

7.31

1.3

1.4

53.34

56.53

0.42

121

408

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

828

5526

0.81

7.29

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

148

485

1.67

7.28

1.6

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

238

1.97

7.25

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

170

580

1.60

7.17

1.0

0.39

0.53

u/ml

0.53

163

568

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

158

530

1.63

7.13

3.1

1.97

1.77

ratio

0.81

142

488

(3011897) Casein IgE Ab [Units/volume] in Serum

278

1.89

7.12

1.2

0.28

0.40

u/ml

0.30

271

(3026692) Albumin [Mass/volume] in Peritoneal fluid

138

447

1.69

7.10

1.4

1.2

11.65

14.48

g/l

2.61

350

(4035726) Immunohistochemistry procedure

3423

16962

1.11

7.08

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

189

2.08

6.99

1.6

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

687

4650

0.80

6.95

1.4

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

187

658

1.55

6.94

2.2

1.8

3245.37

3445.78

e6/l

0.02

117

435

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

109

333

1.79

6.87

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

202

726

1.52

6.83

1.0

1.1

99.85

95.40

1.10

164

579

(40768441) Liver Pathology biopsy report

359

1438

1.37

6.82

1.6

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

170

588

1.58

6.80

1.0

13.07

11.45

u/ml

0.34

107

395

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

117

367

1.74

6.76

1.3

1.2

85.89

88.72

0.19

125

(3043238) Trisomy 21 risk [Likelihood] in Fetus

701

4720

0.81

6.76

1.5

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

452

1878

1.32

6.75

1.9

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

330

1307

1.38

6.73

1.1

16.64

20.16

u/ml

0.97

128

516

(3017354) Segmented neutrophils/Leukocytes in Blood

474

1984

1.31

6.71

2.9

3.8

56.94

57.43

0.19

413

1737

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

253

1.90

6.70

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

121

2.35

6.69

1.1

1.2

129.40

116.71

ug/l

0.19

(3010503) CD19 cells [#/volume] in Blood

290

1127

1.41

6.61

2.8

2.5

270.80

427.45

e6/l

0.53

276

1101

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

908

4108

1.21

6.60

3.2

3.8

805.49

1213.26

u/ml

0.49

821

3742

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

499

2111

1.29

6.54

1.1

97.12

96.34

0.25

470

1992

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.08

6.52

1.3

1.1

—

(3005033) Fetal Nuchal fold Thickness US

678

4561

0.81

6.50

1.4

1.5

1.24

0.05

469

3399

(3022493) Free Hemoglobin [Mass/volume] in Plasma

223

829

1.47

6.45

4.3

6.1

1898.76

1903.24

mg/l

0.00

160

606

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.60

6.33

1.2

1.5

42.12

30.05

0.78

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

175

2.06

6.29

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

268

1.83

6.20

6.4

5.9

45.06

41.53

ug/min

0.16

221

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

148

508

1.59

6.16

1.1

1.80

4.05

u/ml

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

253

1.86

6.15

1.1

1.4

30.50

44.82

mg/l

2.67

217

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

301

1.78

6.12

1.3

1.4

1.16

1.19

mmol/l

1.89

301

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.52

6.11

1.0

3.15

1.68

u/ml

0.19

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.43

6.11

1.0

1.1

0.03

0.17

u/ml

1.58

(3027231) Wheat IgE Ab [Units/volume] in Serum

109

346

1.72

6.10

1.1

0.97

3.13

u/ml

0.49

317

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

115

371

1.69

6.08

1.2

78.04

75.87

0.11

123

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

121

396

1.67

6.07

1.2

1.5

110.27

105.14

0.99

113

373

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.21

6.06

1.0

1.1

0.04

0.22

u/ml

0.49

(3043410) Blood group antigens tested for on Red Blood Cells

139

473

1.61

6.00

1.6

2.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

222

839

1.45

5.94

1.2

1.1

9.42

10.35

mm/h

0.55

222

839

(3015076) Soybean IgE Ab [Units/volume] in Serum

269

1053

1.40

5.94

1.0

0.66

0.60

u/ml

0.10

258

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

187

1.99

5.91

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

207

775

1.46

5.83

2.2

1.8

2.04

2.81

u/ml

0.51

227

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

192

1.96

5.82

2.2

2.4

1.23

1.50

mmol/l

0.30

138

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

2.62

5.81

1.2

1.5

9.48

13.96

0.71

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

267

1.80

5.75

2.5

6.84

7.73

mmol/l

1.17

156

(44806071) Cardiolipin IgM antibody measurement

225

1.87

5.66

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

107

2.30

5.59

1.0

0.26

1.31

u/ml

1.33

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

242

942

1.40

5.55

1.1

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

3.18

5.55

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

857

3928

1.19

5.51

1.4

131.60

148.40

pmol/l

0.39

835

3841

(3018133) Calcium [Moles/volume] in Urine

102

328

1.70

5.50

1.8

2.0

2.53

2.79

mmol/l

0.66

303

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

357

1481

1.32

5.49

1.2

1.3

84.95

80.00

1.06

102

(3004809) Band form neutrophils/Leukocytes in Blood

700

3151

1.22

5.44

2.9

3.7

1.49

1.61

0.40

638

2856

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

197

1.91

5.44

1.9

1.7

1.83

1.86

mg/l

0.06

166

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

551

2422

1.25

5.37

1.9

2.0

30.84

26.01

ug/l

0.49

541

2380

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

270

1.76

5.32

1.2

1.3

65.48

110.13

ng/l

0.75

197

(3036670) Protein [Mass/volume] in Synovial fluid

145

517

1.53

5.21

1.3

40.33

41.38

g/l

0.37

285

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

111

2.21

5.18

1.6

1.3

19.77

13.89

pmol/l

0.40

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

140

2.07

5.17

1.1

1.79

4.40

umol/24h

0.50

140

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

721

3274

1.21

5.15

1.2

1.78

1.12

0.47

153

(3044007) Cell count panel - Peritoneal fluid

154

558

1.51

5.14

2.4

1.8

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.69

5.10

1.1

1.4

0.69

1.02

umol/24h

0.21

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.51

5.09

1.0

1.1

6.89

22.25

u/ml

1.99

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

119

2.16

5.09

1.1

79.66

96.00

titre

0.94

119

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

252

1004

1.37

5.08

1.1

—

(3016750) Collection duration of Urine

255

1019

1.37

5.05

2.5

2.4

511.05

496.85

min

1.79

193

785

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

164

1.97

5.05

1.0

0.21

1.16

u/ml

0.76

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

197

753

1.43

5.05

3.5

3.6

8.18

8.51

mg/l

0.22

154

616

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

235

932

1.38

4.89

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

235

932

1.38

4.89

1.4

1.5

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

4.86

1.0

0.0

341.67

—

ug/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.44

4.85

1.1

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

159

1.96

4.84

1.8

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

167

1.93

4.82

1.0

1.09

0.82

u/ml

0.11

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

104

350

1.62

4.79

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

104

350

1.62

4.79

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

246

987

1.36

4.78

9.3

5.3

696.82

2079.80

u/ml

0.65

143

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

104

351

1.62

4.74

1.0

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

2.53

4.73

1.2

1.3

0.53

1.89

1.16

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

116

2.12

4.70

1.0

0.35

1.32

u/ml

0.85

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

4.10

4.66

1.1

1.0

0.09

0.22

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

177

1.88

4.65

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.38

4.62

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

155

577

1.47

4.60

2.1

1.7

12910.10

14538.69

e6/l

0.08

294

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

229

1680

0.74

4.56

1.5

1.6

7.96

7.58

mmol/l

1.62

212

1612

(3017400) Magnesium [Moles/volume] in Urine

3.57

4.48

1.1

1.2

3.14

2.56

mmol/l

0.31

(3036603) Volume of Urine

349

1489

1.28

4.45

1.5

1.7

2051.50

1927.64

1.47

342

1453

(44806420) Estimation of glomerular filtration rate

450

1980

1.24

4.44

2.5

2.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

815

5191

0.85

4.43

1.6

1.7

—

(4268621) Lupus anticoagulant assay

477

2113

1.23

4.42

2.3

—

(3008037) Lactate [Moles/volume] in Venous blood

937

4417

1.16

4.39

3.6

2.9

1.58

1.55

mmol/l

0.34

912

4311

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.46

4.39

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

626

4069

0.84

4.36

1.5

1.6

59.02

59.98

ug/l

0.21

626

4069

(3034891) Synovial lining cells/cells in Synovial fluid

219

878

1.36

4.33

1.4

1.5

2.67

5.02

1.50

210

(3013336) Amino acids [Identifier] in Serum or Plasma

3.64

4.32

4.2

3.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

174

1.85

4.31

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

164

1.87

4.19

1.0

1.11

10.14

u/ml

0.45

(40762887) Creatinine [Moles/volume] in Blood

111

2.07

4.16

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.47

4.11

1.1

1.5

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.49

4.11

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

175

683

1.40

4.08

1.9

2.2

—

(3024316) Viscosity of Plasma

2.24

4.08

2.5

2.0

1.85

1.67

mpas

0.36

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.30

4.07

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.79

4.06

1.2

1.3

29.77

67.06

umol/24h

0.56

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

4.05

1.2

0.0

24.82

—

nmol/l

—

(3033099) Centromere Ab [Titer] in Serum

128

472

1.48

4.03

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

224

1.71

3.96

1.1

5.62

7.53

u/ml

0.48

224

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

173

678

1.39

3.96

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

173

678

1.39

3.96

2.0

2.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.17

3.93

1.2

1.1

43.39

61.56

u/l

0.55

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

160

1.84

3.93

1.0

4.19

0.51

u/ml

0.51

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.22

3.92

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

398

1759

1.24

3.83

1.4

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

126

469

1.47

3.82

1.7

1.6

9.01

9.26

ug/l

0.28

126

469

(3026250) Tacrolimus [Mass/volume] in Blood

238

987

1.32

3.82

40.7

41.2

7.41

7.29

ug/l

0.39

215

896

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.26

3.81

1.1

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

218

894

1.33

3.78

1.7

2.26

3.54

u/field

1.01

156

642

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

128

479

1.46

3.78

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

128

479

1.46

3.78

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

128

479

1.46

3.78

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

128

479

1.46

3.78

1.2

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

231

957

1.32

3.74

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

231

957

1.32

3.74

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

231

957

1.32

3.74

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

187

1.75

3.74

1.4

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.80

3.72

1.0

297.60

169.13

pmol/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

231

958

1.32

3.72

1.9

—

(3016228) CD19 cells/cells in Blood

185

745

1.36

3.63

2.3

1.9

9.15

8.12

0.59

175

733

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

193

1.73

3.62

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

185

1.74

3.61

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

353

1552

1.24

3.59

1.7

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

179

720

1.36

3.55

2.0

1.6

59883.64

18776.24

u/ml

0.35

104

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

220

1560

0.77

3.53

1.5

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

340

1493

1.25

3.51

3.1

3.0

42.30

59.87

mg/l

0.81

255

1070

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

123

1.91

3.51

1.7

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

311

1353

1.26

3.49

1.9

1.8

1.60

1.85

u/field

0.40

165

766

(3017704) Immunofixation for Urine

226

945

1.31

3.46

1.4

1.7

—

(40762365) Oxygen content in Arterial blood by calculation

243

1.62

3.40

4.7

3.0

14.69

14.67

ml/dl

0.01

232

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

113

1.93

3.39

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

461

2099

1.20

3.37

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.15

3.36

1.6

3.5

6.47

2.10

mu/l

0.65

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

361

1.50

3.36

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

112

419

1.46

3.36

2.2

2.8

135.56

105.18

ng/l

0.36

236

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

227

1.64

3.36

1.1

1.0

0.01

0.22

u/ml

0.71

153

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1445

7138

1.11

3.34

3.4

3.9

366.58

2178.98

u/ml

2.88

1238

6232

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

194

1.69

3.33

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

224

1.63

3.30

1.2

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

179

1.71

3.25

1.2

1.3

5.28

7.07

mmol/l

1.46

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

119

1.88

3.23

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

108

1.92

3.19

1.1

7.53

9.94

u/l

0.43

108

(3027035) Albumin [Mass/time] in 24 hour Urine

168

1.72

3.17

1.3

1.4

341.64

475.43

mg/24h

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.10

3.17

1.2

1.1

1.04

1.17

u/field

0.35

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.06

3.14

1.1

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

303

1335

1.24

3.09

1.5

12.72

12.90

u/l

0.18

294

1292

(3044590) Delta aminolevulinate [Moles/volume] in Urine

7.64

3.09

1.0

14.00

14.80

umol/l

—

(3010375) cycloSPORINE [Mass/volume] in Blood

209

881

1.30

3.07

31.1

30.5

110.87

115.60

ug/l

0.47

163

741

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

180

744

1.32

3.04

1.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

448

0.61

3.01

1.3

1.2

60.30

69.39

ug/l

0.92

448

(3006576) Bicarbonate [Moles/volume] in Blood

145

581

1.36

3.01

6.3

6.7

24.37

25.06

mmol/l

1.04

133

522

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

367

1.46

2.97

6.7

7.5

64.12

72.89

2.16

292

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

122

476

1.40

2.97

1.2

1.1

57.67

65.77

u/ml

0.57

117

465

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

139

1.77

2.96

1.5

1.3

—

(3013466) aPTT in Blood by Coagulation assay

1.94

2.86

1.0

1.1

35.66

39.27

1.98

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

251

1.55

2.84

1.7

1.4

107147.88

241211.91

nmol/l

0.42

216

(3042733) HLA Ab [Presence] in Serum

173

721

1.31

2.80

4.5

5.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.13

2.78

1.2

1.1

798.80

388.88

u/l

0.34

(3036071) Salmonella sp Ab [Titer] in Serum

144

586

1.34

2.75

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.53

2.70

1.0

1.1

2727.82

3026.71

titre

0.18

(36303858) Crystals [Presence] in Urine

3.53

2.70

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.96

2.68

1.0

4.46

1.50

u/ml

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

4.85

2.67

1.0

—

(3025577) Chromium [Mass/volume] in Blood

235

1026

1.25

2.66

2.2

1.95

2.42

ug/l

1.93

196

862

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

216

1.57

2.66

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

165

1.65

2.65

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

195

1.60

2.63

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.11

2.62

1.0

1.1

422.21

263.34

nmol/l

0.45

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

9465

53228

0.96

2.61

4.4

21.54

22.20

3.58

4130

26066

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.90

2.58

1.7

2.0

187.54

198.83

ng/l

0.42

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

244

1.52

2.58

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.88

2.57

1.4

1.8

0.64

0.68

umol/l

0.22

(3026470) Cobalt [Mass/volume] in Blood

240

1055

1.24

2.57

2.3

2.2

2.89

3.94

ug/l

2.01

221

977

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

183

0.45

2.54

1.1

1.0

1.19

1.20

mom

0.01

183

(3029612) Listeria sp Ab [Titer] in Serum

2.84

2.52

1.3

—

(3042628) Porphyrins [Moles/volume] in Urine

6.55

2.50

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

102

1.82

2.50

1.2

1.4

2587.87

1286.39

u/l

0.28

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

147

1.67

2.50

2.6

3.8

1.99

2.28

mg/l

0.47

129

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

143

592

1.32

2.47

2.2

1.9

1.81

1.71

ratio

0.28

133

576

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

123

1.73

2.45

1.1

15.60

37.89

u/ml

1.34

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

123

1.73

2.45

1.1

27.66

29.05

u/ml

—

(40757373) Influenza virus identified in Isolate

302

1.45

2.40

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

289

1.46

2.38

1.4

1.7

104.13

111.45

ug/l

0.21

236

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

116

1.74

2.38

1.0

1.1

3.09

7.28

u/ml

1.34

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.86

2.37

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.84

2.37

1.1

1.5

22.15

21.30

mmol/l

0.45

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.85

2.35

1.5

1.3

19.00

59.37

e6/l

—

(3034426) Prothrombin time (PT)

141

588

1.31

2.34

1.2

27.73

28.33

0.68

141

588

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.48

2.32

1.1

2.33

3.30

0.58

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.32

2.31

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.32

2.31

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

355

1.40

2.30

1.0

1.1

26.07

30.83

iu/ml

0.41

355

(21494814) CD8 cells/Lymphocytes in Specimen

180

777

1.27

2.30

2.3

1.9

30.51

32.14

0.77

180

777

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

102

1.77

2.24

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7148

40300

0.96

2.23

3.1

3.2

0.68

0.81

ug/l

14.12

4683

25493

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.92

2.18

1.7

1.6

0.00

0.05

u/l

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

103

1.75

2.18

1.4

1.1

35.38

21.24

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

4.25

2.18

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.87

2.17

1.0

0.17

0.15

u/ml

0.09

(3050794) Legionella sp Ab [Presence] in Serum

175

1.56

2.16

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

247

1113

1.21

2.16

6.8

7.7

80.22

105.08

ug/l

0.13

164

753

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

174

755

1.26

2.15

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

358

1671

1.17

2.12

4.4

4.3

69.63

68.59

u/ml

0.02

351

1652

(4211845) Urine protein measurement

194

857

1.24

2.07

3.3

2.9

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.75

2.04

1.1

2.32

3.41

u/l

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.87

2.03

1.0

0.16

0.24

u/ml

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

331

1544

1.17

2.00

1.8

4.01

4.00

mg/l

0.01

317

1492

(3013945) Hepatitis B virus e Ab [Presence] in Serum

102

1.71

1.99

1.4

1.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

171

1.53

1.96

2.5

2.76

3.30

mg/l

0.76

163

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.11

1.90

1.0

1.35

4.58

u/ml

1.20

(3037692) Legionella sp identified in Specimen by Organism specific culture

158

691

1.25

1.88

1.6

1.4

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.21

1.87

1.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.37

1.86

1.0

0.19

0.88

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

338

1.36

1.84

1.2

1.4

1433591.67

13795.75

u/ml

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

255

1.41

1.83

1.8

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

101

1.68

1.81

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

115

486

1.29

1.81

1.3

40.10

38.72

0.14

327

(3002621) Streptococcal DNAse B [Units/volume] in Serum

184

1.48

1.78

1.0

1.1

484.57

283.88

u/ml

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.88

1.76

1.0

4.11

14.71

mg/l

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.67

1.75

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

300

1407

1.17

1.74

2.5

2.4

696.61

674.66

0.37

224

985

(3004541) Aldosterone [Moles/volume] in Urine

4.55

1.74

1.0

1.2

43.80

38.33

nmol/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

111

470

1.29

1.74

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

382

1828

1.14

1.69

1.4

6.58

6.19

mmol/l

1.51

356

1721

(3006462) Nitrate [Presence] in Urine

174

780

1.22

1.68

3.4

3.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.10

1.68

1.0

0.18

0.07

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

794

3966

1.09

1.65

4.1

3.0

25.99

28.32

mg/l

0.93

527

2782

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

247

1.39

1.64

1.1

—

(3000285) Sodium [Moles/volume] in Blood

347

1.32

1.59

1.3

1.2

138.87

138.42

mmol/l

0.53

304

(3020393) Adenovirus Ag [Presence] in Stool

180

1.46

1.59

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

257

1201

1.17

1.59

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

220

1016

1.18

1.57

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

163

1.47

1.56

1.1

9.96

10.14

mg/l

0.04

150

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

170

768

1.21

1.55

2.1

9.11

9.53

mg/l

0.44

143

639

(3047189) Immunofixation for 24 hour Urine

184

838

1.20

1.54

1.8

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

175

794

1.20

1.53

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

279

1.35

1.52

1.3

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.72

1.51

1.0

0.20

0.05

u/ml

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

120

1.55

1.50

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

201

1.41

1.49

3.2

2.8

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

125

1.53

1.48

2.9

3.3

27.57

552.83

pmol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

125

1.53

1.48

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

130

1.51

1.45

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.79

1.42

1.1

1.2

1.25

0.87

u/field

1.16

(3006567) Chloride [Moles/time] in 24 hour Urine

2.22

1.42

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.67

1.39

11.1

9.5

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

145

1.47

1.38

2.8

2.0

58.25

62.77

0.29

(40768446) Kidney Pathology biopsy report

186

859

1.18

1.37

1.6

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

535

2651

1.10

1.37

1.3

7.10

7.08

mmol/l

0.04

475

2319

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.03

1.37

7.1

5.1

0.24

0.27

mmol/l

0.13

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

126

561

1.23

1.36

1.8

1.7

137.32

128.12

au/ml

0.07

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

139

626

1.21

1.35

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

295

1.31

1.34

2.6

3.94

ug/l

0.00

105

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.65

1.33

1.1

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

482

2381

1.11

1.33

2.4

2.5

28.61

27.84

iu/ml

0.04

252

(40759632) Porphyrins [Mass/mass] in Stool

2.73

1.32

1.5

1.1

—

(3032641) Amino acids panel - Urine

2.73

1.32

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

544

0.78

1.32

1.2

1.3

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.75

1.28

1.0

0.04

0.25

u/ml

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.63

1.28

1.3

1.2

25.68

23.91

u/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

307

1.30

1.28

1.7

1.6

—

(3049233) Organic acids panel - Urine

3.03

1.28

1.2

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.86

1.27

1.1

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

753

3807

1.08

1.26

1.8

1.6

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.30

1.24

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.30

1.24

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.30

1.24

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.30

1.24

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.30

1.24

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.30

1.24

2.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

552

2757

1.09

1.24

3.6

3.7

30.18

42.32

u/ml

2.10

530

2660

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

109

1.50

1.21

2.7

2.0

14.00

17.26

0.21

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

138

0.59

1.17

1.1

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

108

483

1.22

1.16

1.8

2.0

27.65

34.17

u/l

0.34

448

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

219

1042

1.15

1.16

2.2

173.43

743.16

pmol/l

0.79

191

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

100

666

0.82

1.15

7.1

6.6

8.98

8.81

0.11

100

666

(40761995) Spermatozoa Progressive [#/volume] in Semen

100

666

0.82

1.15

3.6

3.3

44.44

45.06

0.10

100

666

(3027874) Urate [Moles/volume] in Urine

1.61

1.15

1.0

1.1

1.78

9.39

mmol/l

0.49

(3013862) HLA-DP [Type]

0.54

1.14

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

111

1.48

1.13

1.6

1.7

—

(3034614) HLA Ag [Interpretation]

1.87

1.13

1.5

1.1

—

(3019174) dRVVT (LA screen)

143

1.41

1.12

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

199

1.34

1.12

1.2

1.4

24.27

24.22

0.00

155

(3007542) Rye IgE Ab [Units/volume] in Serum

1.50

1.11

1.0

1.02

17.60

u/ml

0.47

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

324

1.26

1.11

1.3

1.4

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

129

591

1.19

1.10

1.5

1.4

60.45

63.37

0.42

109

485

(3044009) aPTT.lupus sensitive (LA screen)

153

1.39

1.10

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

205

1.33

1.08

2.5

2.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.25

1.08

1.0

5.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.25

1.08

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

210

1.33

1.08

2.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

388

1923

1.10

1.06

1.3

1.4

9.55

8.19

mmol/l

6.31

374

1839

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

528

2655

1.09

1.06

1.4

3.56

3.99

ug/l

0.26

463

2365

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.82

1.06

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

12265

66008

1.02

1.05

5.2

5.4

2.23

3.27

ug/l

6.52

10971

60516

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

136

1.41

1.05

1.1

5.22

21.19

iu/ml

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

245

1.29

1.03

2.7

2.8

86.56

78.56

pmol/l

0.07

216

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.97

1.03

1.0

1.1

1274.44

2670.80

titre

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

124

1.41

0.98

2.0

2.1

0.64

0.68

ug/l

0.23

124

(3029396) Erythrocyte agglutination [Presence] in Blood

647

0.83

0.98

2.8

3.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

316

1564

1.10

0.93

2.0

1.8

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.73

0.92

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.56

0.92

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.45

0.91

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

779

4512

0.94

0.89

4.9

3.6

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.90

0.88

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.82

0.85

1.1

69.34

68.81

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

188

910

1.13

0.84

1.1

1.2

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.83

0.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.47

0.82

1.2

2770.87

4641.50

ng/l

0.47

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

101

1.41

0.82

5.9

4.5

—

(3003577) Lead [Moles/volume] in Blood

167

1.31

0.82

1.5

1.6

0.39

0.38

umol/l

0.02

(3022670) pH of Venous cord blood

1.75

0.81

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

201

1.28

0.81

1.0

1.1

23.60

19.82

u/l

0.54

127

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

1.42

0.81

1.0

1.3

—

438.57

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.48

0.78

1.1

—

(40768806) Pleura Pathology biopsy report

390

1970

1.08

0.77

1.6

1.5

—

(46236302) HLA-C [Type] by High resolution typing

0.61

0.77

1.0

—

(40760410) HLA-B [Type] by High resolution

0.61

0.77

1.0

—

(40760409) HLA-A [Type] by High resolution

0.61

0.77

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

227

1.25

0.77

1.2

1.3

100.38

158.56

titre

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.49

0.76

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.69

0.76

1.6

1.3

411.89

370.24

mg/24h

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

117

1.35

0.75

1.5

1.2

251.07

320.03

umol/24h

1.61

117

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.82

0.73

1.1

1.0

—

(3024932) HLA-DR beta [Type]

141

679

1.13

0.72

1.0

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.51

0.71

1.1

0.06

0.04

g/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

235

1.23

0.70

1.1

1.3

5.99

5.90

mmol/l

0.34

235

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.42

0.70

1.1

0.32

1.95

u/ml

1.00

(3014178) Parietal cell Ab [Units/volume] in Serum

1.95

0.70

1.0

1.2

94.60

63.93

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

435

0.84

0.68

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

417

1.17

0.67

2.3

2.1

—

(3006598) pH of Arterial cord blood

1.62

0.66

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.49

0.65

1.1

0.04

0.02

g/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

116

1.32

0.64

5.6

3.2

27.28

8.98

2.20

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.65

0.64

1.4

1.0

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.63

0.0

1.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.62

0.62

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

136

1.28

0.62

1.0

0.25

0.89

u/ml

0.43

(3032868) Hemoglobin electrophoresis panel in Blood

190

1.24

0.61

1.4

1.5

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

151

1.27

0.61

1.3

1.4

1.07

1.68

ml/s/173m2

0.52

(3021162) Amylase [Enzymatic activity/volume] in Specimen

346

1.17

0.60

3.9

2.8

2779.06

1337.46

u/l

0.49

306

(3013762) Body weight Measured

1.47

0.58

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

439

1.14

0.58

2.9

2.6

492.21

530.18

ug/l

0.02

439

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.58

0.57

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

308

0.83

0.56

6.1

1.3

7.81

7.32

mmol/l

0.34

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.64

0.56

1.7

1.1

1.67

1.65

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

418

0.86

0.54

1.5

1.4

30.05

22.21

1.09

347

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

105

1.30

0.54

13.9

9.9

338.16

255.43

e6/l

0.20

(3024471) HLA-A [Type]

141

695

1.11

0.54

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.56

0.53

3.0

2.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

585

0.89

0.52

1.3

4.26

3.29

mmol/l

1.32

553

(3007700) Barley IgE Ab [Units/volume] in Serum

1.31

0.52

1.0

1.75

12.98

u/ml

0.41

(4281824) Cell count and differential, peritoneal fluid

394

2030

1.06

0.52

1.2

1.1

—

(3014891) Appearance of Pleural fluid

220

1.19

0.51

1.8

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

276

1.17

0.50

2.3

2.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

322

1.15

0.50

1.3

1.2

0.72

49.47

mg/l

1.42

230

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.32

0.48

1.2

0.07

g/l

0.11

(3045788) Cell count panel - Pleural fluid

366

1888

1.06

0.48

1.6

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.66

0.48

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

132

1.24

0.47

5.4

6.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

284

0.85

0.47

1.3

1.2

54.12

305.36

u/l

0.86

200

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

370

1.14

0.47

2.1

1.6

1.92

3.86

ug/l

0.83

233

(3035611) Eosinophils/Leukocytes in Synovial fluid

108

1.26

0.46

1.7

1.6

0.91

0.55

0.63

(3003434) Protein [Mass/volume] in Pleural fluid

503

2622

1.05

0.45

1.5

33.28

33.07

g/l

0.13

468

2372

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

123

1.24

0.45

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.51

0.44

4.1

4.6

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.48

0.43

4.4

3.6

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.43

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

114

1.25

0.43

3.1

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

726

3821

1.04

0.43

4.0

3.0

7.38

7.52

mmol/l

0.65

704

3741

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

159

802

1.08

0.41

1.1

1.3

957.58

1052.85

titre

0.40

193

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

0.03

0.04

u/ml

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

378

0.88

0.41

6.0

6.9

10.64

10.54

0.12

378

(3001729) Color of Synovial fluid

130

1.22

0.40

1.7

1.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

277

1.14

0.40

1.5

10.71

13.02

0.25

144

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.36

0.39

7.9

9.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

366

1.12

0.38

5.0

6.3

1398.00

9470.46

iu/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

444

2321

1.04

0.38

1.5

2762.15

2526.47

e6/l

0.13

314

1617

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

204

1044

1.07

0.38

1.4

5.77

5.56

mmol/l

1.87

190

988

(4133840) Spirometry

105

627

0.91

0.37

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

396

2071

1.04

0.35

1.6

1.5

66648.49

44723.80

e6/l

0.54

229

1155

(3009677) Dengue virus Ab [Presence] in Serum

1.25

0.34

1.1

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

106

533

1.09

0.33

1.5

1.4

3.29

2.28

0.75

444

(3051101) Glucose [Moles/volume] in Cord blood

325

0.89

0.32

5.2

5.7

8.07

8.34

mmol/l

0.36

325

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.36

0.32

1.0

2.02

0.62

u/ml

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

103

0.79

0.32

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

282

1469

1.05

0.31

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

201

1.14

0.31

2.4

2.3

0.67

0.54

u/field

0.33

201

(40765089) Chromosome analysis panel - Blood by G-banded

137

701

1.07

0.29

1.0

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

474

1.08

0.29

1.6

1.4

23.64

19.81

0.64

421

(3010937) Rubella virus Ab [Presence] in Serum

124

0.84

0.27

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

593

3150

1.03

0.26

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

117

1.17

0.25

3.9

3.3

—

(3041184) Isoniazid [Presence] in Urine

1.36

0.24

2.0

2.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.36

0.24

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.30

0.23

1.0

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

150

779

1.05

0.22

1.7

1.6

3723.64

3622.04

titre

0.06

141

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

121

0.86

0.21

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.84

0.20

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

120

1.14

0.20

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.17

0.19

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

141

1.12

0.19

1.0

—

(3035880) pH of Pleural fluid

192

1009

1.04

0.18

1.3

7.38

7.41

0.94

130

719

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

339

1801

1.03

0.18

1.4

1.3

497.23

463.51

u/l

0.16

319

1713

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

184

1.10

0.17

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

369

1.07

0.17

1.2

1.48

1.65

mmol/l

0.63

236

(3012989) Citrate [Moles/time] in 24 hour Urine

1.15

0.16

1.4

1.2

1.80

2.16

mmol/24h

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

236

0.93

0.15

1.3

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

195

1098

0.97

0.14

1.4

32.32

35.65

nmol/l

0.65

168

1035

(3038071) Oxygen [Partial pressure] in Mixed venous blood

496

0.96

0.12

5.9

7.8

5.76

5.51

kpa

0.40

496

(40765096) Chromosome analysis panel by Banding

106

601

0.96

0.12

1.2

—

(21494434) Karyotype in Bone marrow

309

1720

0.98

0.11

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.87

0.11

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

373

2003

1.02

0.10

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.15

0.10

1.1

1.2

29.76

33.02

mg/24h

0.23

(3020618) Glucose [Moles/volume] in Synovial fluid

1.12

0.09

1.0

1.1

5.91

5.19

mmol/l

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.12

0.09

1.1

1.4

1.17

1.07

u/field

—

(3022475) Manganese [Moles/volume] in Blood

105

1.09

0.09

1.0

1.3

0.18

0.15

umol/l

1.17

105

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.11

0.08

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

152

0.93

0.08

2.3

2.4

—

(3013727) Leukocytes other/Leukocytes in Blood

117

622

1.03

0.08

3.1

3.5

52.63

52.46

0.03

117

593

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

162

866

1.02

0.08

2.8

3.5

1.37

1.24

0.46

162

866

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

268

0.96

0.07

6.8

9.1

0.36

0.33

umol/l

0.24

244

(3003157) Bacteria [#/volume] in Mother's milk

0.85

0.07

5.0

6.7

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.86

0.07

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

214

1.05

0.07

1.2

0.06

0.32

u/ml

—

(40758358) Immune stain study

1.09

0.06

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.11

0.05

1.3

1.1

214.40

248.54

u/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

263

1421

1.01

0.04

1.3

12.70

14.47

u/l

0.67

248

1313

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.94

0.04

1.4

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

520

1.02

0.04

1.3

141.75

207.28

ug/l

0.30

278

(4038314) Semen analysis, post vasectomy

198

0.96

0.04

1.3

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.06

0.04

5.0

11.3

109.42

106.43

g/l

0.42

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

115

0.95

0.03

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

109

1.05

0.03

1.0

1.1

1.04

0.90

u/ml

0.07

(3045142) Bone marrow Pathology biopsy report

413

2268

0.99

0.03

1.3

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.06

0.03

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

100

553

0.99

0.02

5.9

8.1

5.94

5.98

kpa

0.16

497

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.05

0.02

3.8

3.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

315

0.99

0.00

1.2

1.3

0.88

1.53

mmol/l

0.81

207

(3026726) Creatinine [Moles/volume] in Specimen

171

1.02

0.00

2.2

2.4

182.44

268.55

umol/l

0.86

164

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

264

1.01

0.00

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.05

0.00

3.0

2.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

107

1.02

0.00

1.0

1.1

7.97

8.71

mmol/l

1.56

107

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

206

1.01

0.00

3.1

2.9

1.30

1.39

mg/l

0.13

134

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

155

0.99

0.00

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

134

1.02

0.00

2.6

5.2

—

(4212803) Bone marrow aspirate examination

143

0.99

0.00

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.96

-0.00

2.0

2.1

26.85

26.33

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

-0.00

0.0

10.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.01

-0.00

1.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.6

—

138.80

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_DEPRESSION_DYSTHYMIA – Depression or dysthymia

GWS hits: 83

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Depression or dysthymia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Depression or dysthymia (F5_DEPRESSION_DYSTHYMIA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints